N-CSR 1 filing877.htm PRIMARY DOCUMENT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES


Investment Company Act file number   811-21667


Fidelity Central Investment Portfolios LLC

 (Exact name of registrant as specified in charter)


245 Summer St., Boston, Massachusetts 02210

 (Address of principal executive offices)       (Zip code)


Cynthia Lo Bessette, Secretary

245 Summer St.

Boston, Massachusetts  02210

(Name and address of agent for service)



Registrant's telephone number, including area code:

617-563-7000



Date of fiscal year end:

June 30



Date of reporting period:

June 30, 2022




Item 1.

Reports to Stockholders




Fidelity® U.S. Equity Central Fund



Annual Report

June 30, 2022

Fidelity Investments



Fidelity Investments

Contents

Note to Shareholders

Performance

Management's Discussion of Fund Performance

Investment Summary

Schedule of Investments

Financial Statements

Notes to Financial Statements

Report of Independent Registered Public Accounting Firm

Directors and Officers (Trustees and Officers)

Shareholder Expense Example

Distributions

Board Approval of Investment Advisory Contracts and Management Fees

Liquidity Risk Management Program


To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.

You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.

Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.

Other third-party marks appearing herein are the property of their respective owners.

All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company. © 2022 FMR LLC. All rights reserved.



A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC’s web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.



Note to Shareholders:

Early in 2020, the outbreak and spread of COVID-19 emerged as a public health emergency that had a major influence on financial markets, primarily based on its impact on the global economy and corporate earnings. On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, citing sustained risk of further global spread. The pandemic prompted a number of measures to limit the spread of COVID-19, including travel and border restrictions, quarantines, and restrictions on large gatherings. In turn, these resulted in lower consumer activity, diminished demand for a wide range of products and services, disruption in manufacturing and supply chains, and – given the wide variability in outcomes regarding the outbreak – significant market uncertainty and volatility. To help stem the turmoil, the U.S. government took unprecedented action – in concert with the U.S. Federal Reserve and central banks around the world – to help support consumers, businesses, and the broader economy, and to limit disruption to the financial system.

In general, the overall impact of the pandemic lessened in 2021, amid a resilient economy and widespread distribution of three COVID-19 vaccines granted emergency use authorization from the U.S. Food and Drug Administration (FDA) early in the year. Still, the situation remains dynamic, and the extent and duration of its influence on financial markets and the economy is highly uncertain, due in part to a recent spike in cases based on highly contagious variants of the coronavirus.

Extreme events such as the COVID-19 crisis are exogenous shocks that can have significant adverse effects on mutual funds and their investments. Although multiple asset classes may be affected by market disruption, the duration and impact may not be the same for all types of assets. Fidelity is committed to helping you stay informed amid news about COVID-19 and during increased market volatility, and we continue to take extra steps to be responsive to customer needs. We encourage you to visit us online, where we offer ongoing updates, commentary, and analysis on the markets and our funds.

Performance: The Bottom Line

Average annual total return reflects the change in the value of an investment, assuming reinvestment of distributions from dividend income and capital gains (the profits earned upon the sale of securities that have grown in value, if any) and assuming a constant rate of performance each year. The hypothetical investment and the average annual total returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. During periods of reimbursement by Fidelity, a fund’s total return will be greater than it would be had the reimbursement not occurred. How a fund did yesterday is no guarantee of how it will do tomorrow.

Average Annual Total Returns

For the periods ended June 30, 2022 Past 1 year Life of fundA 
Fidelity® U.S. Equity Central Fund (15.73)% 7.27% 

 A From September 18, 2020

$10,000 Over Life of Fund

Let's say hypothetically that $10,000 was invested in Fidelity® U.S. Equity Central Fund on September 18, 2020, when the fund started.

The chart shows how the value of your investment would have changed, and also shows how the MSCI U.S. Investable Market 2500 Index performed over the same period.


Period Ending Values

$11,332Fidelity® U.S. Equity Central Fund

$11,554MSCI U.S. Investable Market 2500 Index

Management's Discussion of Fund Performance

Market Recap:  The S&P 500® index returned -10.62% for the 12 months ending June 30, 2022, as a multitude of crosscurrents challenged the global economy and financial markets. Persistently high inflation, exacerbated by energy price shocks from the Russia–Ukraine conflict, spurred the U.S. Federal Reserve to hike interest rates more aggressively than anticipated, and concerns about the outlook for economic growth sent stocks into bear market territory. Against this backdrop, the index returned -8.72% in April amid clearer signals of the Fed’s intention to tighten monetary policy. In early May, the Fed approved a rare half-percentage-point interest rate increase and announced plans to shrink its $9 trillion asset portfolio. The S&P 500® gained 0.18% for the month. June began with the Fed allowing up to billions in Treasuries and mortgage bonds to mature every month without reinvesting the proceeds. Two weeks later, the central bank raised rates by 0.75 percentage points, its largest increase since 1994, and said it was becoming more difficult to achieve a soft landing, in which the economy slows enough to bring down inflation while avoiding a recession. Partly in reaction, the S&P 500 returned -8.25% in June and -19.96% since the end of 2021 – its worst first-half result to begin a year since 1970. For the full 12 months, the growth-oriented communication services (-29%) and consumer discretionary (-24%) sectors lagged most. In contrast, energy (+40%) rode a surge in commodity prices and led by a wide margin, followed by defensive sectors, such as utilities (+14%).

Comments from Portfolio Manager Robert Stansky:  For the fiscal year ending June 30, 2022, the fund returned -15.73%, trailing the -13.77% result of the benchmark MSCI U.S. Investable Market 2500 Index. Versus the benchmark, security selection was the primary detractor. The pharmaceuticals, biotechnology & life sciences segment of the health care sector hurt the most by far. Weak stock picks in consumer discretionary and industrials also hampered the fund's relative result. Not owning Chevron, a benchmark component that gained roughly 44%, was the largest individual relative detractor. Avoiding Pfizer, a benchmark component that rose about 38%, proved to be our second-largest relative detractor this period. Sidestepping AbbVie, a benchmark component that advanced 42%, also was detrimental to relative performance. In contrast, the biggest contributor to performance versus the benchmark was security selection in financials. Picks among information technology stocks boosted the fund's relative performance to a lesser extent. The fund's largest individual relative contributor was an overweighting in Travelers Companies, which gained about 16% the past year. The stock was among our biggest holdings as of June 30. An out-of-benchmark position in MEG Energy (+92%) also added value. Another notable relative contributor was the portfolio’s outsized exposure to Exxon Mobil (+42%), which was one of our largest holdings at period end. Notable changes in positioning included a reduced allocation to the communication services sector and higher exposure to consumer staples companies.

The views expressed above reflect those of the portfolio manager(s) only through the end of the period as stated on the cover of this report and do not necessarily represent the views of Fidelity or any other person in the Fidelity organization. Any such views are subject to change at any time based upon market or other conditions and Fidelity disclaims any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Fidelity fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any Fidelity fund.

Investment Summary (Unaudited)

Top Ten Stocks as of June 30, 2022

 % of fund's net assets 
Microsoft Corp. 6.6 
Apple, Inc. 6.4 
Alphabet, Inc. Class A 3.9 
Amazon.com, Inc. 2.9 
UnitedHealth Group, Inc. 1.7 
Exxon Mobil Corp. 1.4 
Bank of America Corp. 1.4 
Meta Platforms, Inc. Class A 1.4 
The Travelers Companies, Inc. 1.2 
Tesla, Inc. 1.1 
 28.0 

Market Sectors as of June 30, 2022

 % of fund's net assets 
Information Technology 25.5 
Health Care 14.5 
Consumer Discretionary 11.1 
Financials 10.7 
Communication Services 8.8 
Industrials 8.6 
Consumer Staples 6.5 
Energy 4.3 
Real Estate 3.5 
Utilities 3.0 
Materials 2.8 

Asset Allocation (% of fund's net assets)

As of June 30, 2022* 
   Stocks and Equity Futures 99.2% 
   Convertible Securities 0.3% 
   Short-Term Investments and Net Other Assets (Liabilities) 0.5% 


 * Foreign investments - 7.9%

Schedule of Investments June 30, 2022

Showing Percentage of Net Assets

Common Stocks - 98.9%   
 Shares Value 
COMMUNICATION SERVICES - 8.7%   
Diversified Telecommunication Services - 0.2%   
Liberty Global PLC Class C (a) 1,650,518 $36,459,943 
Entertainment - 1.6%   
Activision Blizzard, Inc. 544,325 42,381,145 
Cinemark Holdings, Inc. (a)(b) 570,500 8,568,910 
Electronic Arts, Inc. 376,696 45,825,068 
Endeavor Group Holdings, Inc. (a) 316,300 6,503,128 
Lions Gate Entertainment Corp.:   
Class A (a)(b) 89,400 832,314 
Class B (a) 610,626 5,391,828 
Marcus Corp. (a)(b) 420,200 6,206,354 
Netflix, Inc. (a) 309,105 54,053,191 
Take-Two Interactive Software, Inc. (a) 157,760 19,330,333 
The Walt Disney Co. (a) 666,620 62,928,928 
Warner Bros Discovery, Inc. (a) 125,288 1,681,365 
Warner Music Group Corp. Class A 230,600 5,617,416 
World Wrestling Entertainment, Inc. Class A (b) 137,824 8,612,622 
  267,932,602 
Interactive Media & Services - 5.6%   
Alphabet, Inc. Class A (a) 297,550 648,438,813 
Angi, Inc. (a)(b) 991,732 4,542,133 
IAC (a) 15,000 1,139,550 
Meta Platforms, Inc. Class A (a) 1,401,325 225,963,656 
Snap, Inc. Class A (a) 1,025,200 13,460,876 
Twitter, Inc. (a) 551,900 20,635,541 
Zoominfo Technologies, Inc. (a) 148,000 4,919,520 
  919,100,089 
Media - 0.6%   
Advantage Solutions, Inc. Class A (a) 2,286,269 8,687,822 
Altice U.S.A., Inc. Class A (a) 848,200 7,845,850 
Comcast Corp. Class A 993,182 38,972,462 
DISH Network Corp. Class A (a) 77,263 1,385,326 
Liberty Broadband Corp.:   
Class A (a) 62,800 7,130,940 
Class C (a) 311,400 36,010,296 
S4 Capital PLC (a) 740,200 2,065,196 
TechTarget, Inc. (a) 27,700 1,820,444 
  103,918,336 
Wireless Telecommunication Services - 0.7%   
T-Mobile U.S., Inc. (a) 858,938 115,561,519 
TOTAL COMMUNICATION SERVICES  1,442,972,489 
CONSUMER DISCRETIONARY - 11.0%   
Auto Components - 0.0%   
Adient PLC (a) 175,764 5,207,887 
Automobiles - 1.2%   
Ferrari NV 46,691 8,566,865 
Tesla, Inc. (a) 283,550 190,948,241 
  199,515,106 
Hotels, Restaurants & Leisure - 2.1%   
Airbnb, Inc. Class A (a) 156,900 13,976,652 
ARAMARK Holdings Corp. 709,994 21,747,116 
Booking Holdings, Inc. (a) 32,400 56,667,276 
Brinker International, Inc. (a) 164,500 3,623,935 
Caesars Entertainment, Inc. (a) 571,828 21,901,012 
Chipotle Mexican Grill, Inc. (a) 20,527 26,834,126 
Churchill Downs, Inc. 138,750 26,574,788 
Compass Group PLC 587 12,052 
Domino's Pizza, Inc. 46,600 18,160,486 
Dutch Bros, Inc. (b) 189,080 5,984,382 
Flutter Entertainment PLC (a) 97,300 9,764,465 
Hilton Worldwide Holdings, Inc. 400,271 44,606,200 
Lindblad Expeditions Holdings (a) 429,849 3,481,777 
Marriott International, Inc. Class A 303,900 41,333,439 
McDonald's Corp. 35,409 8,741,774 
Noodles & Co. (a) 862,335 4,052,975 
Penn National Gaming, Inc. (a) 285,400 8,681,868 
Planet Fitness, Inc. (a) 201,607 13,711,292 
Ruth's Hospitality Group, Inc. 194,793 3,167,334 
Vail Resorts, Inc. 39,179 8,542,981 
Wingstop, Inc. (b) 96,027 7,179,939 
  348,745,869 
Household Durables - 0.2%   
D.R. Horton, Inc. 149,520 9,896,729 
Lennar Corp. Class A 171,576 12,108,118 
Tempur Sealy International, Inc. 291,100 6,220,807 
Tupperware Brands Corp. (a)(b) 123,109 780,511 
  29,006,165 
Internet & Direct Marketing Retail - 3.2%   
Amazon.com, Inc. (a) 4,452,840 472,936,136 
eBay, Inc. 434,000 18,084,780 
Uber Technologies, Inc. (a) 1,688,012 34,536,726 
  525,557,642 
Multiline Retail - 0.6%   
Dollar General Corp. 151,961 37,297,308 
Dollar Tree, Inc. (a) 168,006 26,183,735 
Ollie's Bargain Outlet Holdings, Inc. (a) 227,159 13,345,591 
Target Corp. 127,300 17,978,579 
  94,805,213 
Specialty Retail - 2.0%   
Aritzia, Inc. (a) 177,000 4,792,146 
Bath & Body Works, Inc. 203,974 5,490,980 
Burlington Stores, Inc. (a) 255,850 34,854,446 
Dick's Sporting Goods, Inc. 89,318 6,731,898 
Five Below, Inc. (a) 155,129 17,596,282 
Floor & Decor Holdings, Inc. Class A (a) 281,516 17,724,247 
Lowe's Companies, Inc. 463,530 80,964,785 
Ross Stores, Inc. 251,047 17,631,031 
The Home Depot, Inc. 309,413 84,862,704 
TJX Companies, Inc. 902,586 50,409,428 
Victoria's Secret & Co. (a) 207,857 5,813,760 
Warby Parker, Inc. (a)(b) 420,000 4,729,200 
  331,600,907 
Textiles, Apparel & Luxury Goods - 1.7%   
adidas AG 39,314 6,983,385 
Capri Holdings Ltd. (a) 1,582,602 64,902,508 
Crocs, Inc. (a) 80,100 3,898,467 
Deckers Outdoor Corp. (a) 90,417 23,087,981 
Levi Strauss & Co. Class A (b) 254,287 4,149,964 
lululemon athletica, Inc. (a) 126,567 34,503,430 
LVMH Moet Hennessy Louis Vuitton SE 14,691 9,003,791 
NIKE, Inc. Class B 657,752 67,222,254 
On Holding AG 306,200 5,416,678 
PVH Corp. 398,621 22,681,535 
Ralph Lauren Corp. (b) 64,370 5,770,771 
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) 81,100 2,885,538 
Tapestry, Inc. 1,236,410 37,735,233 
  288,241,535 
TOTAL CONSUMER DISCRETIONARY  1,822,680,324 
CONSUMER STAPLES - 6.5%   
Beverages - 2.2%   
Boston Beer Co., Inc. Class A (a) 107,600 32,599,572 
Celsius Holdings, Inc. (a) 5,500 358,930 
Constellation Brands, Inc. Class A (sub. vtg.) 134,166 31,268,728 
Diageo PLC 104,581 4,517,138 
Keurig Dr. Pepper, Inc. 843,001 29,833,805 
Molson Coors Beverage Co. Class B 48,900 2,665,539 
Monster Beverage Corp. (a) 567,478 52,605,211 
PepsiCo, Inc. 204,700 34,115,302 
Primo Water Corp. 135,200 1,808,976 
The Coca-Cola Co. 2,832,691 178,204,591 
  367,977,792 
Food & Staples Retailing - 0.8%   
Albertsons Companies, Inc. 52,300 1,397,456 
BJ's Wholesale Club Holdings, Inc. (a) 39,000 2,430,480 
Grocery Outlet Holding Corp. (a) 40,700 1,735,041 
Performance Food Group Co. (a) 559,957 25,746,823 
Sprouts Farmers Market LLC (a) 4,900 124,068 
Sysco Corp. 33,900 2,871,669 
The Real Good Food Co. LLC Class B (c) 156,156 
U.S. Foods Holding Corp. (a) 662,608 20,328,813 
Walgreens Boots Alliance, Inc. 3,300 125,070 
Walmart, Inc. 689,400 83,817,252 
  138,576,674 
Food Products - 1.0%   
Archer Daniels Midland Co. 24,100 1,870,160 
Bunge Ltd. 162,200 14,709,918 
Conagra Brands, Inc. 237,500 8,132,000 
Darling Ingredients, Inc. (a) 108,700 6,500,260 
Freshpet, Inc. (a)(b) 113,400 5,884,326 
Ingredion, Inc. 1,400 123,424 
Laird Superfood, Inc. (a) 119,100 227,481 
Lamb Weston Holdings, Inc. 421,075 30,090,020 
Mondelez International, Inc. 960,412 59,631,981 
Nomad Foods Ltd. (a) 345,000 6,896,550 
Sanderson Farms, Inc. 8,800 1,896,664 
Sovos Brands, Inc. 13,289 210,896 
The Hain Celestial Group, Inc. (a) 33,100 785,794 
The Real Good Food Co. LLC Class B unit (d) 156,156 1,097,777 
The Simply Good Foods Co. (a) 5,700 215,289 
TreeHouse Foods, Inc. (a) 472,403 19,755,893 
Tyson Foods, Inc. Class A 115,700 9,957,142 
  167,985,575 
Household Products - 1.4%   
Energizer Holdings, Inc. 458,815 13,007,405 
Kimberly-Clark Corp. 209,600 28,327,440 
Procter & Gamble Co. 1,103,193 158,628,121 
Reckitt Benckiser Group PLC 345 25,948 
Reynolds Consumer Products, Inc. 548,920 14,969,048 
Spectrum Brands Holdings, Inc. 41,200 3,379,224 
The Clorox Co. 118,900 16,762,522 
  235,099,708 
Personal Products - 0.4%   
Edgewell Personal Care Co. 251,300 8,674,876 
Estee Lauder Companies, Inc. Class A 47,600 12,122,292 
Herbalife Nutrition Ltd. (a) 1,132,613 23,161,936 
Olaplex Holdings, Inc. 118,200 1,665,438 
Shiseido Co. Ltd. 47,000 1,894,438 
The Beauty Health Co. (a) 135,000 1,736,100 
The Beauty Health Co. (a)(e) 600,000 7,716,000 
The Honest Co., Inc. (a) 66,540 194,297 
Unilever PLC 99,691 4,543,896 
  61,709,273 
Tobacco - 0.7%   
Altria Group, Inc. 883,567 36,906,594 
Philip Morris International, Inc. 725,453 71,631,229 
RLX Technology, Inc. ADR (a) 990,900 2,110,617 
  110,648,440 
TOTAL CONSUMER STAPLES  1,081,997,462 
ENERGY - 4.3%   
Energy Equipment & Services - 0.5%   
Baker Hughes Co. Class A 105,354 3,041,570 
Halliburton Co. 913,400 28,644,224 
Helmerich & Payne, Inc. 103,700 4,465,322 
Liberty Oilfield Services, Inc. Class A (a) 702,400 8,962,624 
Nextier Oilfield Solutions, Inc. (a) 487,600 4,637,076 
Schlumberger Ltd. 964,600 34,494,096 
Valaris Ltd. (a) 31,200 1,317,888 
Weatherford International PLC (a) 196,700 4,164,139 
  89,726,939 
Oil, Gas & Consumable Fuels - 3.8%   
Antero Resources Corp. (a) 606,400 18,586,160 
Canadian Natural Resources Ltd. 1,200,659 64,519,564 
CVR Energy, Inc. 122,200 4,093,700 
Delek U.S. Holdings, Inc. 295,200 7,627,968 
Exxon Mobil Corp. 2,808,438 240,514,630 
Genesis Energy LP 1,762,600 14,136,052 
Hess Corp. 711,075 75,331,286 
Imperial Oil Ltd. 589,200 27,775,525 
Kosmos Energy Ltd. (a) 3,262,873 20,197,184 
MEG Energy Corp. (a) 4,486,750 62,114,578 
Peabody Energy Corp. (a)(b) 206,600 4,406,778 
Phillips 66 Co. 255,559 20,953,282 
Range Resources Corp. (a) 325,400 8,053,650 
Tourmaline Oil Corp. 397,200 20,653,042 
Valero Energy Corp. 403,486 42,882,492 
  631,845,891 
TOTAL ENERGY  721,572,830 
FINANCIALS - 10.7%   
Banks - 5.1%   
Bank of America Corp. 7,270,641 226,335,054 
Bank of Ireland Group PLC 3,617,100 22,864,537 
BankUnited, Inc. 179,448 6,382,965 
BNP Paribas SA 346,470 16,572,344 
Citizens Financial Group, Inc. 518,075 18,490,097 
Comerica, Inc. 226,945 16,653,224 
First Horizon National Corp. 694,763 15,187,519 
JPMorgan Chase & Co. 553,573 62,337,856 
M&T Bank Corp. 235,339 37,510,683 
Piraeus Financial Holdings SA (a) 3,343,502 3,283,783 
PNC Financial Services Group, Inc. 275,332 43,439,130 
Signature Bank 82,093 14,711,887 
Silvergate Capital Corp. (a) 49,000 2,622,970 
Societe Generale Series A 968,937 21,422,918 
Standard Chartered PLC (United Kingdom) 559,610 4,224,718 
Starling Bank Ltd. Series D (a)(c)(e) 4,618,325 13,256,410 
Sumitomo Mitsui Financial Group, Inc. 217,200 6,456,291 
SVB Financial Group (a) 33,425 13,202,541 
U.S. Bancorp 2,052,680 94,464,334 
UniCredit SpA 1,834,529 17,531,390 
Wells Fargo & Co. 4,536,771 177,705,320 
Wintrust Financial Corp. 154,127 12,353,279 
  847,009,250 
Capital Markets - 1.8%   
Bank of New York Mellon Corp. 1,995,051 83,213,577 
BlackRock, Inc. Class A 83,009 50,555,801 
Brookfield Asset Management, Inc. Class A 387,520 17,233,014 
Cboe Global Markets, Inc. 149,002 16,865,536 
Goldman Sachs Group, Inc. 9,265 2,751,890 
Intercontinental Exchange, Inc. 491,907 46,258,934 
Lazard Ltd. Class A 347,547 11,263,998 
Patria Investments Ltd. 898,838 11,882,638 
State Street Corp. 429,890 26,502,719 
StepStone Group, Inc. Class A 403,631 10,506,515 
TMX Group Ltd. 91,100 9,271,364 
Virtu Financial, Inc. Class A 587,001 13,741,693 
  300,047,679 
Consumer Finance - 0.5%   
American Express Co. 317,444 44,004,087 
Capital One Financial Corp. 171,485 17,867,022 
OneMain Holdings, Inc. 598,604 22,375,818 
  84,246,927 
Diversified Financial Services - 0.1%   
Ant International Co. Ltd. Class C (a)(c)(e) 5,601,170 11,370,375 
Jumo World Ltd. (c) 998 4,497,437 
  15,867,812 
Insurance - 2.9%   
AIA Group Ltd. 505,200 5,520,103 
Arch Capital Group Ltd. (a) 566,427 25,766,764 
Arthur J. Gallagher & Co. 242,958 39,611,872 
Chubb Ltd. 107,400 21,112,692 
Globe Life, Inc. 356,213 34,720,081 
Hartford Financial Services Group, Inc. 801,673 52,453,464 
Marsh & McLennan Companies, Inc. 475,356 73,799,019 
Prudential PLC 446,819 5,558,087 
Reinsurance Group of America, Inc. 160,200 18,789,858 
The Travelers Companies, Inc. 1,152,204 194,872,263 
Unum Group 431,700 14,686,434 
  486,890,637 
Thrifts & Mortgage Finance - 0.3%   
Essent Group Ltd. 667,333 25,959,254 
MGIC Investment Corp. 1,191,030 15,006,978 
Mr. Cooper Group, Inc. (a) 20 735 
  40,966,967 
TOTAL FINANCIALS  1,775,029,272 
HEALTH CARE - 14.3%   
Biotechnology - 2.6%   
ADC Therapeutics SA (a) 281,100 2,234,745 
Agios Pharmaceuticals, Inc. (a) 200,000 4,434,000 
Alnylam Pharmaceuticals, Inc. (a) 190,000 27,711,500 
Ambrx Biopharma, Inc. ADR 148,700 394,055 
Arcutis Biotherapeutics, Inc. (a) 233,100 4,967,361 
Argenx SE ADR (a) 150,000 56,832,000 
Ascendis Pharma A/S sponsored ADR (a) 267,700 24,885,392 
Atara Biotherapeutics, Inc. (a) 540,000 4,206,600 
Beam Therapeutics, Inc. (a)(b) 120,000 4,645,200 
BeiGene Ltd. ADR (a) 31,500 5,098,275 
Blueprint Medicines Corp. (a) 230,000 11,617,300 
Celldex Therapeutics, Inc. (a) 190,000 5,122,400 
Century Therapeutics, Inc. 240,000 2,016,000 
Cerevel Therapeutics Holdings (a) 400,000 10,576,000 
Cytokinetics, Inc. (a) 560,000 22,002,400 
Denali Therapeutics, Inc. (a) 180,000 5,297,400 
Erasca, Inc. 750,000 4,177,500 
Exelixis, Inc. (a) 460,000 9,577,200 
Fate Therapeutics, Inc. (a)(b) 90,000 2,230,200 
Generation Bio Co. (a) 240,000 1,574,400 
Graphite Bio, Inc. 236,200 649,550 
Imago BioSciences, Inc. 90,000 1,205,100 
Innovent Biologics, Inc. (a)(d) 2,280,000 10,140,694 
Instil Bio, Inc. (a) 440,000 2,032,800 
Intellia Therapeutics, Inc. (a) 150,000 7,764,000 
Janux Therapeutics, Inc. 160,000 1,953,600 
Keros Therapeutics, Inc. (a) 125,000 3,453,750 
Legend Biotech Corp. ADR (a) 315,000 17,325,000 
Mirati Therapeutics, Inc. (a) 54,000 3,625,020 
Nuvalent, Inc. Class A (a) 157,400 2,134,344 
Poseida Therapeutics, Inc. (a) 511,800 1,320,444 
PTC Therapeutics, Inc. (a) 319,900 12,815,194 
Regeneron Pharmaceuticals, Inc. (a) 95,000 56,157,350 
Relay Therapeutics, Inc. (a) 450,000 7,537,500 
Sarepta Therapeutics, Inc. (a) 140,000 10,494,400 
Scholar Rock Holding Corp. (a) 60,000 329,400 
Shattuck Labs, Inc. (a) 280,000 1,136,800 
Stoke Therapeutics, Inc. (a) 157,500 2,080,575 
uniQure B.V. (a) 180,000 3,355,200 
Vaxcyte, Inc. (a) 260,000 5,657,600 
Vertex Pharmaceuticals, Inc. (a) 105,000 29,587,950 
Verve Therapeutics, Inc. 70,000 1,069,600 
Xencor, Inc. (a) 450,000 12,316,500 
Xenon Pharmaceuticals, Inc. (a) 145,696 4,432,072 
Zai Lab Ltd. (a) 2,000,000 6,818,066 
Zentalis Pharmaceuticals, Inc. (a) 350,000 9,835,000 
  424,827,437 
Health Care Equipment & Supplies - 2.2%   
Boston Scientific Corp. (a) 3,450,000 128,581,500 
Envista Holdings Corp. (a) 500,000 19,270,000 
Hologic, Inc. (a) 140,000 9,702,000 
Insulet Corp. (a) 318,000 69,304,920 
Masimo Corp. (a) 120,000 15,680,400 
Novocure Ltd. (a) 100,000 6,950,000 
Outset Medical, Inc. (a) 240,000 3,566,400 
Penumbra, Inc. (a) 445,000 55,411,400 
PROCEPT BioRobotics Corp. 200,000 6,538,000 
ResMed, Inc. 185,000 38,781,550 
Tandem Diabetes Care, Inc. (a) 320,000 18,940,800 
  372,726,970 
Health Care Providers & Services - 4.3%   
1Life Healthcare, Inc. (a) 500,000 3,920,000 
agilon health, Inc. (a) 1,700,000 37,111,000 
Alignment Healthcare, Inc. (a) 856,600 9,773,806 
Cano Health, Inc. (a)(b) 2,350,000 10,293,000 
Centene Corp. (a) 700,000 59,227,000 
Cigna Corp. 335,000 88,279,200 
Guardant Health, Inc. (a) 190,000 7,664,600 
HCA Holdings, Inc. 165,000 27,729,900 
Humana, Inc. 250,000 117,017,500 
LifeStance Health Group, Inc. 1,280,000 7,116,800 
Oak Street Health, Inc. (a) 1,850,000 30,414,000 
Surgery Partners, Inc. (a) 650,000 18,798,000 
The Oncology Institute, Inc. (e) 761,936 3,855,396 
UnitedHealth Group, Inc. 560,000 287,632,800 
  708,833,002 
Health Care Technology - 0.4%   
Change Healthcare, Inc. (a) 600,000 13,836,000 
Definitive Healthcare Corp. (b) 160,000 3,668,800 
Doximity, Inc. (b) 350,000 12,187,000 
Inspire Medical Systems, Inc. (a) 131,900 24,094,173 
Medlive Technology Co. Ltd. (d) 800,000 1,176,531 
Phreesia, Inc. (a) 280,000 7,002,800 
  61,965,304 
Life Sciences Tools & Services - 2.6%   
10X Genomics, Inc. (a) 241,262 10,917,106 
Agilent Technologies, Inc. 169,000 20,072,130 
Avantor, Inc. (a) 650,000 20,215,000 
Bio-Rad Laboratories, Inc. Class A (a) 40,000 19,800,000 
Bruker Corp. 420,000 26,359,200 
Charles River Laboratories International, Inc. (a) 60,000 12,838,200 
Danaher Corp. 540,000 136,900,800 
Eden Biologics, Inc. (a)(c) 1,008,062 
Lonza Group AG 42,000 22,433,773 
Nanostring Technologies, Inc. (a) 220,000 2,794,000 
Olink Holding AB ADR (a) 350,000 5,320,000 
Quanterix Corp. (a) 150,000 2,428,500 
Sartorius Stedim Biotech 23,518 7,376,454 
Seer, Inc. (a) 315,115 2,820,279 
Stevanato Group SpA 350,000 5,533,500 
Thermo Fisher Scientific, Inc. 210,000 114,088,800 
West Pharmaceutical Services, Inc. 100,000 30,237,000 
  440,134,742 
Pharmaceuticals - 2.2%   
Arvinas Holding Co. LLC (a) 211,555 8,904,350 
AstraZeneca PLC (United Kingdom) 400,000 52,768,723 
Bristol-Myers Squibb Co. 570,000 43,890,000 
Chime Biologics Wuhan Co. Ltd. (a)(c) 1,008,062 525,029 
Eli Lilly & Co. 460,000 149,145,800 
Merck & Co., Inc. 180,000 16,410,600 
Pharvaris BV (a) 208,000 4,596,800 
Roche Holding AG (participation certificate) 100,000 33,429,985 
Royalty Pharma PLC 1,340,000 56,333,600 
Theseus Pharmaceuticals, Inc. 180,000 995,400 
UCB SA 64,000 5,408,428 
  372,408,715 
TOTAL HEALTH CARE  2,380,896,170 
INDUSTRIALS - 8.6%   
Aerospace & Defense - 1.8%   
Axon Enterprise, Inc. (a) 65,000 6,056,050 
HEICO Corp. Class A 112,161 11,819,526 
Howmet Aerospace, Inc. 442,600 13,919,770 
L3Harris Technologies, Inc. 193,210 46,698,857 
Lockheed Martin Corp. 158,700 68,234,652 
Northrop Grumman Corp. 46,500 22,253,505 
Raytheon Technologies Corp. 688,598 66,181,154 
The Boeing Co. (a) 455,600 62,289,632 
  297,453,146 
Air Freight & Logistics - 0.1%   
Air Transport Services Group, Inc. (a) 379,300 10,897,289 
Airlines - 0.2%   
Delta Air Lines, Inc. (a) 752,200 21,791,234 
JetBlue Airways Corp. (a) 1,609,200 13,469,004 
  35,260,238 
Building Products - 0.9%   
Carlisle Companies, Inc. 259,778 61,985,629 
Fortune Brands Home & Security, Inc. 534,076 31,980,471 
The AZEK Co., Inc. (a) 367,900 6,158,646 
Trane Technologies PLC 433,710 56,325,918 
  156,450,664 
Commercial Services & Supplies - 0.9%   
Cintas Corp. 178,528 66,685,564 
Copart, Inc. (a) 62,302 6,769,735 
CoreCivic, Inc. (a) 288,300 3,203,013 
Waste Connections, Inc. (United States) 556,572 68,992,665 
  145,650,977 
Construction & Engineering - 0.3%   
Willscot Mobile Mini Holdings (a) 1,721,900 55,823,998 
Electrical Equipment - 0.5%   
AMETEK, Inc. 788,132 86,607,825 
Industrial Conglomerates - 0.2%   
Honeywell International, Inc. 207,313 36,033,073 
Machinery - 2.0%   
AGCO Corp. 305,800 30,182,460 
Caterpillar, Inc. 400,583 71,608,217 
Chart Industries, Inc. (a)(b) 182,000 30,463,160 
Deere & Co. 188,900 56,569,883 
Fortive Corp. 1,501,194 81,634,930 
IDEX Corp. 218,871 39,753,540 
ITT, Inc. 298,500 20,071,140 
  330,283,330 
Marine - 0.1%   
Eagle Bulk Shipping, Inc. 122,700 6,365,676 
Genco Shipping & Trading Ltd. 248,400 4,799,088 
  11,164,764 
Professional Services - 0.3%   
Equifax, Inc. 112,696 20,598,575 
TransUnion Holding Co., Inc. 366,295 29,299,937 
  49,898,512 
Road & Rail - 1.3%   
CSX Corp. 2,924,178 84,976,613 
Landstar System, Inc. 293,285 42,649,505 
Old Dominion Freight Lines, Inc. 87,183 22,343,259 
Union Pacific Corp. 265,716 56,671,908 
  206,641,285 
Trading Companies & Distributors - 0.0%   
Air Lease Corp. Class A 125,800 4,205,494 
TOTAL INDUSTRIALS  1,426,370,595 
INFORMATION TECHNOLOGY - 25.5%   
Communications Equipment - 0.2%   
Cisco Systems, Inc. 749,200 31,945,888 
Electronic Equipment & Components - 0.5%   
Cognex Corp. 205,522 8,738,795 
Corning, Inc. 978,777 30,841,263 
TE Connectivity Ltd. 255,341 28,891,834 
Teledyne Technologies, Inc. (a) 21,700 8,139,887 
Trimble, Inc. (a) 102,453 5,965,838 
  82,577,617 
IT Services - 4.1%   
Affirm Holdings, Inc. (a)(b) 227,725 4,112,714 
Akamai Technologies, Inc. (a) 382,605 34,943,315 
AvidXchange Holdings, Inc. (b) 56,800 348,752 
Block, Inc. Class A (a) 62,000 3,810,520 
Capgemini SA 391,617 67,079,069 
Cognizant Technology Solutions Corp. Class A 1,267,977 85,575,768 
Cyxtera Technologies, Inc. (a)(e) 319,903 3,627,700 
Cyxtera Technologies, Inc. Class A (a) 463,791 5,259,390 
DXC Technology Co. (a) 165,783 5,024,883 
ExlService Holdings, Inc. (a) 110,566 16,289,689 
Gartner, Inc. (a) 94,135 22,764,667 
Global Payments, Inc. 318,800 35,272,032 
GoDaddy, Inc. (a) 524,300 36,470,308 
MasterCard, Inc. Class A 334,400 105,496,512 
MongoDB, Inc. Class A (a) 116,100 30,127,950 
PayPal Holdings, Inc. (a) 556,152 38,841,656 
Repay Holdings Corp. (a) 889,044 11,424,215 
Snowflake, Inc. (a) 60,900 8,468,754 
StoneCo Ltd. Class A (a)(b) 145,800 1,122,660 
Thoughtworks Holding, Inc. 75,500 1,065,305 
Twilio, Inc. Class A (a) 265,800 22,276,698 
Visa, Inc. Class A 666,100 131,148,429 
Wix.com Ltd. (a) 145,500 9,537,525 
Worldline SA (a)(d) 144,976 5,375,198 
  685,463,709 
Semiconductors & Semiconductor Equipment - 2.6%   
Advanced Micro Devices, Inc. (a) 468,971 35,862,212 
Analog Devices, Inc. 962,961 140,678,972 
Intel Corp. 1,046,900 39,164,529 
Lam Research Corp. 15,800 6,733,170 
Marvell Technology, Inc. 338,244 14,723,761 
Microchip Technology, Inc. 918,404 53,340,904 
Micron Technology, Inc. 1,580,511 87,370,648 
NVIDIA Corp. 157,600 23,890,584 
onsemi (a) 182,500 9,181,575 
Skyworks Solutions, Inc. 172,063 15,939,916 
  426,886,271 
Software - 11.6%   
Adobe, Inc. (a) 411,049 150,468,597 
Alteryx, Inc. Class A (a) 148,700 7,200,054 
Aspen Technology, Inc. (a) 68,590 12,598,611 
Autodesk, Inc. (a) 345,532 59,417,683 
Black Knight, Inc. (a) 189,900 12,417,561 
Blackbaud, Inc. (a) 230,000 13,356,100 
Blend Labs, Inc. (b) 284,300 670,948 
Braze, Inc. (b) 25,800 934,734 
Ceridian HCM Holding, Inc. (a) 370,100 17,424,308 
Citrix Systems, Inc. 51,440 4,998,425 
Constellation Software, Inc. 11,190 16,611,743 
Coupa Software, Inc. (a) 122,400 6,989,040 
Elastic NV (a) 285,900 19,346,853 
Five9, Inc. (a) 24,800 2,260,272 
GitLab, Inc. 18,500 983,090 
HashiCorp, Inc. 21,500 632,960 
HubSpot, Inc. (a) 70,204 21,106,833 
Micro Focus International PLC 751,494 2,557,191 
Microsoft Corp. 4,246,159 1,090,541,007 
Momentive Global, Inc. (a) 329,600 2,900,480 
New Relic, Inc. (a)(b) 152,300 7,622,615 
NortonLifeLock, Inc. 1,490,710 32,735,992 
Palo Alto Networks, Inc. (a)(b) 166,530 82,255,828 
PTC, Inc. (a) 344,057 36,587,021 
Roper Technologies, Inc. 135,300 53,396,145 
Salesforce.com, Inc. (a) 984,638 162,504,656 
Samsara, Inc. (b) 70,500 787,485 
Smartsheet, Inc. (a) 67,800 2,130,954 
Tenable Holdings, Inc. (a) 672,700 30,547,307 
Workday, Inc. Class A (a) 304,689 42,528,491 
Workiva, Inc. (a) 54,200 3,576,658 
Zendesk, Inc. (a) 431,600 31,968,612 
Zoom Video Communications, Inc. Class A (a) 88,700 9,576,939 
  1,939,635,193 
Technology Hardware, Storage & Peripherals - 6.5%   
Apple, Inc. 7,779,132 1,063,562,927 
Western Digital Corp. (a) 329,014 14,749,698 
  1,078,312,625 
TOTAL INFORMATION TECHNOLOGY  4,244,821,303 
MATERIALS - 2.8%   
Chemicals - 1.9%   
Air Products & Chemicals, Inc. 85,089 20,462,203 
Albemarle Corp. 102,200 21,357,756 
Ashland Global Holdings, Inc. 30,100 3,101,805 
CF Industries Holdings, Inc. 291,900 25,024,587 
Corteva, Inc. 377,800 20,454,092 
DuPont de Nemours, Inc. 236,207 13,128,385 
Eastman Chemical Co. 33,900 3,043,203 
Ecolab, Inc. 125,601 19,312,410 
Element Solutions, Inc. 189,300 3,369,540 
FMC Corp. 28,252 3,023,247 
Huntsman Corp. 112,100 3,178,035 
International Flavors & Fragrances, Inc. 111,920 13,331,910 
Linde PLC 219,500 63,112,835 
Livent Corp. (a)(b) 161,900 3,673,511 
LyondellBasell Industries NV Class A 120,600 10,547,676 
Nutrien Ltd. 183,300 14,597,641 
Olin Corp. 224,584 10,393,748 
PPG Industries, Inc. 89,300 10,210,562 
RPM International, Inc. 57,700 4,542,144 
Sherwin-Williams Co. 108,983 24,402,384 
The Mosaic Co. 260,100 12,284,523 
The Scotts Miracle-Gro Co. Class A (b) 20,300 1,603,497 
Tronox Holdings PLC 917,300 15,410,640 
Wacker Chemie AG 18,500 2,667,662 
  322,233,996 
Construction Materials - 0.1%   
Martin Marietta Materials, Inc. 30,722 9,193,251 
Summit Materials, Inc. (a) 126,540 2,947,117 
Vulcan Materials Co. 64,200 9,122,820 
  21,263,188 
Containers & Packaging - 0.2%   
Aptargroup, Inc. 44,100 4,551,561 
Avery Dennison Corp. 48,900 7,915,443 
Ball Corp. 141,700 9,744,709 
Crown Holdings, Inc. 96,295 8,875,510 
Packaging Corp. of America 33,800 4,647,500 
  35,734,723 
Metals & Mining - 0.5%   
Alcoa Corp. 279,200 12,725,936 
Commercial Metals Co. 158,156 5,234,964 
Compass Minerals International, Inc. 21,400 757,346 
First Quantum Minerals Ltd. 349,900 6,638,097 
Freeport-McMoRan, Inc. 728,200 21,307,132 
Lundin Mining Corp. 358,900 2,275,190 
Newmont Corp. 343,456 20,494,020 
Reliance Steel & Aluminum Co. 51,400 8,730,804 
Royal Gold, Inc. 29,300 3,128,654 
Steel Dynamics, Inc. 47,900 3,168,585 
  84,460,728 
Paper & Forest Products - 0.1%   
Louisiana-Pacific Corp. 82,000 4,297,620 
West Fraser Timber Co. Ltd. 25,800 1,979,697 
  6,277,317 
TOTAL MATERIALS  469,969,952 
REAL ESTATE - 3.5%   
Equity Real Estate Investment Trusts (REITs) - 3.2%   
Alexandria Real Estate Equities, Inc. 90,400 13,110,712 
American Tower Corp. 227,504 58,147,747 
Crown Castle International Corp. 298,100 50,194,078 
CubeSmart 984,415 42,054,209 
Douglas Emmett, Inc. 299,300 6,698,334 
Duke Realty Corp. 307,500 16,897,125 
EastGroup Properties, Inc. 88,500 13,658,205 
Equinix, Inc. 56,400 37,055,928 
Equity Lifestyle Properties, Inc. 305,600 21,535,632 
Essex Property Trust, Inc. 96,159 25,146,540 
Four Corners Property Trust, Inc. 646,003 17,177,220 
Invitation Homes, Inc. 566,951 20,172,117 
Mid-America Apartment Communities, Inc. 168,200 29,379,494 
Phillips Edison & Co., Inc. (b) 190,900 6,377,969 
Prologis (REIT), Inc. 359,191 42,258,821 
Public Storage 21,100 6,597,337 
RLJ Lodging Trust 783,985 8,647,355 
Ryman Hospitality Properties, Inc. (a) 171,900 13,069,557 
SITE Centers Corp. 843,900 11,367,333 
Spirit Realty Capital, Inc. 208,700 7,884,686 
Terreno Realty Corp. 100,500 5,600,865 
UDR, Inc. 90,700 4,175,828 
Urban Edge Properties 505,400 7,687,134 
Ventas, Inc. 617,400 31,752,882 
VICI Properties, Inc. 597,000 17,784,630 
Washington REIT (SBI) 160,100 3,411,731 
Welltower, Inc. 216,200 17,804,070 
  535,647,539 
Real Estate Management & Development - 0.3%   
CBRE Group, Inc. (a) 320,100 23,562,561 
Digitalbridge Group, Inc. (a) 1,230,100 6,002,888 
Doma Holdings, Inc. Class A (a) 2,667,140 2,747,154 
Jones Lang LaSalle, Inc. (a) 41,500 7,256,690 
WeWork, Inc. (a) 1,483,700 7,448,174 
  47,017,467 
TOTAL REAL ESTATE  582,665,006 
UTILITIES - 3.0%   
Electric Utilities - 2.0%   
American Electric Power Co., Inc. 266,618 25,579,331 
Avangrid, Inc. (b) 91,100 4,201,532 
Constellation Energy Corp. 425,859 24,384,686 
Duke Energy Corp. 93,900 10,067,019 
Edison International 215,682 13,639,730 
Entergy Corp. 221,200 24,915,968 
Eversource Energy 60,100 5,076,647 
Exelon Corp. 621,779 28,179,024 
FirstEnergy Corp. 439,279 16,863,921 
NextEra Energy, Inc. 1,077,817 83,487,705 
OGE Energy Corp. 175,200 6,755,712 
PG&E Corp. (a) 2,084,506 20,803,370 
PNM Resources, Inc. 15,800 754,924 
PPL Corp. 706,700 19,172,771 
Southern Co. 718,055 51,204,502 
  335,086,842 
Gas Utilities - 0.0%   
Southwest Gas Corp. 62,300 5,425,084 
Independent Power and Renewable Electricity Producers - 0.3%   
Clearway Energy, Inc. Class A 44,888 1,435,069 
NextEra Energy Partners LP 126,275 9,364,554 
Sunnova Energy International, Inc. (a) 40,166 740,259 
The AES Corp. 795,896 16,721,775 
Vistra Corp. 634,678 14,502,392 
  42,764,049 
Multi-Utilities - 0.7%   
CenterPoint Energy, Inc. 462,298 13,674,775 
Consolidated Edison, Inc. 16,100 1,531,110 
Dominion Energy, Inc. 405,613 32,371,974 
NiSource, Inc. 578,052 17,046,753 
Public Service Enterprise Group, Inc. 315,900 19,990,152 
Sempra Energy 173,588 26,085,069 
  110,699,833 
TOTAL UTILITIES  493,975,808 
TOTAL COMMON STOCKS   
(Cost $13,135,863,159)  16,442,951,211 
Preferred Stocks - 0.4%   
Convertible Preferred Stocks - 0.3%   
COMMUNICATION SERVICES - 0.1%   
Interactive Media & Services - 0.1%   
Reddit, Inc. Series F (c)(e) 236,672 9,301,210 
CONSUMER DISCRETIONARY - 0.0%   
Internet & Direct Marketing Retail - 0.0%   
Circle Internet Financial Ltd. Series F (e) 160,054 7,723,598 
HEALTH CARE - 0.2%   
Biotechnology - 0.1%   
Asimov, Inc. Series B (c)(e) 35,044 2,321,315 
Caris Life Sciences, Inc. Series D (a)(c)(e) 1,077,331 5,968,414 
Element Biosciences, Inc. Series C (c)(e) 195,016 2,663,919 
ElevateBio LLC Series C (a)(c)(e) 626,000 2,862,698 
Inscripta, Inc. Series E (a)(c)(e) 423,474 2,574,722 
  16,391,068 
Health Care Providers & Services - 0.0%   
dMed Biopharmaceutical Co. Ltd. Series C (a)(c)(e) 416,172 2,996,438 
Health Care Technology - 0.1%   
Aledade, Inc.:   
Series B1 (a)(c)(e) 67,586 3,366,459 
Series E1 (c)(e) 14,822 738,284 
Omada Health, Inc. Series E (c)(e) 597,550 1,649,238 
Wugen, Inc. Series B (c)(e) 155,150 671,800 
  6,425,781 
Pharmaceuticals - 0.0%   
Aristea Therapeutics, Inc. Series B (a)(c)(e) 391,809 3,671,250 
Galvanize Therapeutics Series B (c)(e) 1,112,588 1,926,208 
  5,597,458 
TOTAL HEALTH CARE  31,410,745 
TOTAL CONVERTIBLE PREFERRED STOCKS  48,435,553 
Nonconvertible Preferred Stocks - 0.1%   
CONSUMER DISCRETIONARY - 0.1%   
Internet & Direct Marketing Retail - 0.1%   
Circle Internet Financial Ltd. Series E (e) 388,096 18,728,038 
FINANCIALS - 0.0%   
Diversified Financial Services - 0.0%   
Thriveworks TopCo LLC Series B (c)(e)(f) 141,317 4,056,252 
TOTAL NONCONVERTIBLE PREFERRED STOCKS  22,784,290 
TOTAL PREFERRED STOCKS   
(Cost $72,186,702)  71,219,843 
 Principal Amount Value 
Convertible Bonds - 0.0%   
INFORMATION TECHNOLOGY - 0.0%   
IT Services - 0.0%   
Affirm Holdings, Inc. 0% 11/15/26
(Cost $7,109,200)(d) 
11,914,000 6,669,093 
U.S. Treasury Obligations - 0.2%   
U.S. Treasury Bills, yield at date of purchase 0.66% to 1.7% 7/7/22 to 9/29/22 (g)   
(Cost $26,009,784) 26,120,000 26,013,107 
 Shares Value 
Money Market Funds - 1.7%   
Fidelity Cash Central Fund 1.58% (h) 149,607,652 $149,637,573 
Fidelity Securities Lending Cash Central Fund 1.58% (h)(i) 130,618,752 130,631,814 
TOTAL MONEY MARKET FUNDS   
(Cost $280,269,387)  280,269,387 
TOTAL INVESTMENT IN SECURITIES - 101.2%   
(Cost $13,521,438,232)  16,827,122,641 
NET OTHER ASSETS (LIABILITIES) - (1.2)%  (194,406,327) 
NET ASSETS - 100%  $16,632,716,314 

Futures Contracts      
 Number of contracts Expiration Date Notional Amount Value Unrealized Appreciation/(Depreciation) 
Purchased      
Equity Index Contracts      
CME E-mini S&P 500 Index Contracts (United States) 207 Sept. 2022 $39,221,325 $(4,666) $(4,666) 

The notional amount of futures purchased as a percentage of Net Assets is 0.2%

Legend

 (a) Non-income producing

 (b) Security or a portion of the security is on loan at period end.

 (c) Level 3 security

 (d) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $24,459,293 or 0.1% of net assets.

 (e) Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $111,045,724 or 0.7% of net assets.

 (f) Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

 (g) Security or a portion of the security was pledged to cover margin requirements for futures contracts. At period end, the value of securities pledged amounted to $26,013,107.

 (h) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements, which are not covered by the Fund's Report of Independent Registered Public Accounting Firm, are available on the SEC's website or upon request.

 (i) Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost 
Aledade, Inc. Series B1 5/7/21 $2,587,915 
Aledade, Inc. Series E1 5/20/22 $738,349 
Ant International Co. Ltd. Class C 5/16/18 $21,348,159 
Aristea Therapeutics, Inc. Series B 10/6/20 $2,160,317 
Asimov, Inc. Series B 10/29/21 $3,247,902 
Caris Life Sciences, Inc. Series D 5/11/21 $8,726,381 
Circle Internet Financial Ltd. Series E 5/11/21 $6,298,800 
Circle Internet Financial Ltd. Series F 5/9/22 $6,744,676 
Cyxtera Technologies, Inc. 2/21/21 $3,199,030 
dMed Biopharmaceutical Co. Ltd. Series C 12/1/20 $5,910,953 
Element Biosciences, Inc. Series C 6/21/21 $4,008,885 
ElevateBio LLC Series C 3/9/21 $2,626,070 
Galvanize Therapeutics Series B 3/29/22 $1,926,207 
Inscripta, Inc. Series E 3/30/21 $3,739,275 
Omada Health, Inc. Series E 12/22/21 $3,582,432 
Reddit, Inc. Series F 8/11/21 $14,625,004 
Starling Bank Ltd. Series D 6/18/21 $8,257,037 
The Beauty Health Co. 12/8/20 $6,000,000 
The Oncology Institute, Inc. 6/28/21 $7,619,360 
Thriveworks TopCo LLC Series B 7/23/21 - 2/25/22 $4,060,362 
Wugen, Inc. Series B 7/9/21 $1,203,173 

Affiliated Central Funds

Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.

Fund Value, beginning of period Purchases Sales Proceeds Dividend Income Realized Gain/Loss Change in Unrealized appreciation (depreciation) Value, end of period % ownership, end of period 
Fidelity Cash Central Fund 1.58% $554,315,775 $5,933,434,673 $6,338,112,874 $496,079 $-- $(1) $149,637,573 0.3% 
Fidelity Securities Lending Cash Central Fund 1.58% 52,585,595 1,246,165,839 1,168,119,620 898,482 -- -- 130,631,814 0.3% 
Total $606,901,370 $7,179,600,512 $7,506,232,494 $1,394,561 $-- $(1) $280,269,387  

Amounts in the income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line-item in the Statement of Operations, if applicable. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Investment Valuation

The following is a summary of the inputs used, as of June 30, 2022, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.

 Valuation Inputs at Reporting Date: 
Description Total Level 1 Level 2 Level 3 
Investments in Securities:     
Equities:     
Communication Services $1,452,273,699 $1,442,972,489 $-- $9,301,210 
Consumer Discretionary 1,849,131,960 1,806,681,096 42,450,864 -- 
Consumer Staples 1,081,997,462 1,071,016,040 10,981,420 
Energy 721,572,830 721,572,830 -- -- 
Financials 1,779,085,524 1,668,619,199 77,285,851 33,180,474 
Health Care 2,412,306,915 2,271,738,660 108,632,481 31,935,774 
Industrials 1,426,370,595 1,426,370,595 -- -- 
Information Technology 4,244,821,303 4,242,264,112 2,557,191 -- 
Materials 469,969,952 469,969,952 -- -- 
Real Estate 582,665,006 582,665,006 -- -- 
Utilities 493,975,808 493,975,808 -- -- 
Corporate Bonds 6,669,093 -- 6,669,093 -- 
U.S. Government and Government Agency Obligations 26,013,107 -- 26,013,107 -- 
Money Market Funds 280,269,387 280,269,387 -- -- 
Total Investments in Securities: $16,827,122,641 $16,478,115,174 $274,590,007 $74,417,460 
Derivative Instruments:     
Liabilities     
Futures Contracts $(4,666) $(4,666) $-- $-- 
Total Liabilities $(4,666) $(4,666) $-- $-- 
Total Derivative Instruments: $(4,666) $(4,666) $-- $-- 

Value of Derivative Instruments

The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of June 30, 2022. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.

Primary Risk Exposure / Derivative Type Value 
 Asset Liability 
Equity Risk   
Futures Contracts(a) $0 $(4,666) 
Total Equity Risk (4,666) 
Total Value of Derivatives $0 $(4,666) 

 (a) Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).

See accompanying notes which are an integral part of the financial statements.


Financial Statements

Statement of Assets and Liabilities

  June 30, 2022 
Assets   
Investment in securities, at value (including securities loaned of $126,783,132) — See accompanying schedule:
Unaffiliated issuers (cost $13,241,168,845) 
$16,546,853,254  
Fidelity Central Funds (cost $280,269,387) 280,269,387  
Total Investment in Securities (cost $13,521,438,232)  $16,827,122,641 
Receivable for investments sold  334,420,071 
Receivable for fund shares sold  1,299,777 
Dividends receivable  13,627,218 
Distributions receivable from Fidelity Central Funds  467,244 
Other receivables  9,830 
Total assets  17,176,946,781 
Liabilities   
Payable to custodian bank $141,504  
Payable for investments purchased 25,666,446  
Payable for fund shares redeemed 383,973,831  
Payable for daily variation margin on futures contracts 3,792,432  
Other payables and accrued expenses 24,440  
Collateral on securities loaned 130,631,814  
Total liabilities  544,230,467 
Net Assets  $16,632,716,314 
Net Assets consist of:   
Paid in capital  $13,307,759,357 
Total accumulated earnings (loss)  3,324,956,957 
Net Assets  $16,632,716,314 
Net Asset Value, offering price and redemption price per share ($16,632,716,314 ÷ 162,632,170 shares)  $102.27 

See accompanying notes which are an integral part of the financial statements.


Statement of Operations

  Year ended June 30, 2022 
Investment Income   
Dividends  $257,986,584 
Interest  22,309 
Income from Fidelity Central Funds (including $898,482 from security lending)  1,394,561 
Total income  259,403,454 
Expenses   
Custodian fees and expenses $98,254  
Independent directors' fees and expenses 86,506  
Interest 17,058  
Miscellaneous 189  
Total expenses  202,007 
Net investment income (loss)  259,201,447 
Realized and Unrealized Gain (Loss)   
Net realized gain (loss) on:   
Investment securities:   
Unaffiliated issuers 1,315,742,577  
Redemptions in-kind with affiliated entities 3,072,585,365  
Foreign currency transactions 2,321,013  
Futures contracts 9,775,251  
Total net realized gain (loss)  4,400,424,206 
Change in net unrealized appreciation (depreciation) on:   
Investment securities:   
Unaffiliated issuers (7,649,621,839)  
Fidelity Central Funds (1)  
Unfunded commitments 1,122,983  
Assets and liabilities in foreign currencies (2,690,502)  
Futures contracts (2,016,195)  
Total change in net unrealized appreciation (depreciation)  (7,653,205,554) 
Net gain (loss)  (3,252,781,348) 
Net increase (decrease) in net assets resulting from operations  $(2,993,579,901) 

See accompanying notes which are an integral part of the financial statements.


Statement of Changes in Net Assets

 Year ended June 30, 2022 For the period
September 18, 2020 (commencement of operations) through June 30, 2021 
Increase (Decrease) in Net Assets   
Operations   
Net investment income (loss) $259,201,447 $222,684,363 
Net realized gain (loss) 4,400,424,206 1,867,679,942 
Change in net unrealized appreciation (depreciation) (7,653,205,554) 5,252,737,508 
Net increase (decrease) in net assets resulting from operations (2,993,579,901) 7,343,101,813 
Distributions to shareholders (1,982,604,210) (325,383,396) 
Affiliated share transactions   
Proceeds from sales of shares 1,480,601,338 1,706,447,125 
Net asset value of shares issued in exchange for the net assets of the Target Fund(s) (see Merger information note) – 21,629,434,310 
Reinvestment of distributions 1,982,604,210 325,383,378 
Cost of shares redeemed (10,094,925,893) (2,438,362,460) 
Net increase (decrease) in net assets resulting from share transactions (6,631,720,345) 21,222,902,353 
Total increase (decrease) in net assets (11,607,904,456) 28,240,620,770 
Net Assets   
Beginning of period 28,240,620,770 – 
End of period $16,632,716,314 $28,240,620,770 
Other Information   
Shares   
Sold 11,218,721 14,502,448 
Issued in exchange for the shares of the Target Fund(s) (see Merger Information note) – 216,294,365 
Issued in reinvestment of distributions 15,351,739 2,778,660 
Redeemed (76,700,915) (20,812,848) 
Net increase (decrease) (50,130,455) 212,762,625 

See accompanying notes which are an integral part of the financial statements.


Financial Highlights

Fidelity U.S. Equity Central Fund

   
Years ended June 30, 2022 2021 A 
Selected Per–Share Data   
Net asset value, beginning of period $132.73 $100.00 
Income from Investment Operations   
Net investment income (loss)B,C 1.41 1.05 
Net realized and unrealized gain (loss) (19.85) 33.21 
Total from investment operations (18.44) 34.26 
Distributions from net investment income (1.38) (.87) 
Distributions from net realized gain (10.64) (.66) 
Total distributions (12.02) (1.53) 
Net asset value, end of period $102.27 $132.73 
Total ReturnD,E (15.73)% 34.47% 
Ratios to Average Net AssetsC,F,G   
Expenses before reductions - %H - %H,I 
Expenses net of fee waivers, if any - %H - %H,I 
Expenses net of all reductions - %H - %H,I 
Net investment income (loss) 1.10% 1.12%I 
Supplemental Data   
Net assets, end of period (000 omitted) $16,632,716 $28,240,621 
Portfolio turnover rateJ 34%K 47%I,L 

 A For the period September 18, 2020 (commencement of operations) through June 30, 2021.

 B Calculated based on average shares outstanding during the period.

 C Net investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any such underlying funds is not included in the Fund's net investment income (loss) ratio.

 D Total returns for periods of less than one year are not annualized.

 E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.

 F Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.

 G Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.

 H Amount represents less than .005%.

 I Annualized

 J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).

 K Portfolio turnover rate excludes securities received or delivered in-kind.

 L The portfolio turnover rate does not include the assets acquired in the merger.

See accompanying notes which are an integral part of the financial statements.


Notes to Financial Statements

For the period ended June 30, 2022

1. Organization.

Fidelity U.S. Equity Central Fund (the Fund) is a fund of Fidelity Central Investment Portfolios LLC (the LLC) and is authorized to issue an unlimited number of shares. Shares of the Fund are only offered to other investment companies and accounts managed by Fidelity Management & Research Company LLC (FMR), or its affiliates (the Investing Funds). The LLC is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware Limited Liability Company.

2. Investments in Fidelity Central Funds.

Funds may invest in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Schedule of Investments lists any Fidelity Central Funds held as an investment as of period end, but does not include the underlying holdings of each Fidelity Central Fund. An investing fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.

Based on its investment objective, each Fidelity Central Fund may invest or participate in various investment vehicles or strategies that are similar to those of the investing fund. These strategies are consistent with the investment objectives of the investing fund and may involve certain economic risks which may cause a decline in value of each of the Fidelity Central Funds and thus a decline in the value of the investing fund.

Fidelity Central Fund Investment Manager Investment Objective Investment Practices Expense Ratio(a) 
Fidelity Money Market Central Funds Fidelity Management & Research Company LLC (FMR) Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. Short-term Investments Less than .005% 

 (a) Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.

A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds which contain the significant accounting policies (including investment valuation policies) of those funds, and are not covered by the Report of Independent Registered Public Accounting Firm, are available on the Securities and Exchange Commission website or upon request.

3. Significant Accounting Policies.

The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds (ETFs) but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:

Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Directors (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.

The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:

  • Level 1 – unadjusted quoted prices in active markets for identical investments
  • Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
  • Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, ETFs and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Corporate bonds and U.S. government and government agency obligations are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of June 30, 2022 is included at the end of the Fund's Schedule of Investments.

Foreign Currency. Certain Funds may use foreign currency contracts to facilitate transactions in foreign-denominated securities. Gains and losses from these transactions may arise from changes in the value of the foreign currency or if the counterparties do not perform under the contracts' terms.

Foreign-denominated assets, including investment securities, and liabilities are translated into U.S. dollars at the exchange rates at period end. Purchases and sales of investment securities, income and dividends received, and expenses denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date.

The effects of exchange rate fluctuations on investments are included with the net realized and unrealized gain (loss) on investment securities. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.

Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.

Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.

Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. As of June 30, 2022, the Fund did not have any unrecognized tax benefits in the financial statements; nor is the Fund aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.

Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. In addition, the Fund claimed a portion of the payment made to redeeming shareholders as a distribution for income tax purposes.

Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.

Book-tax differences are primarily due to futures contracts, foreign currency transactions, passive foreign investment companies (PFIC), redemptions in-kind, partnerships and losses deferred due to wash sales.

As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:

Gross unrealized appreciation $4,791,731,317 
Gross unrealized depreciation (1,550,114,294) 
Net unrealized appreciation (depreciation) $3,241,617,023 
Tax Cost $13,585,505,618 

The tax-based components of distributable earnings as of period end were as follows:

Undistributed ordinary income $31,422,169 
Undistributed long-term capital gain $54,875,427 
Net unrealized appreciation (depreciation) on securities and other investments $3,238,659,361 

The tax character of distributions paid was as follows:

 June 30, 2022 June 30, 2021(a) 
Ordinary Income $470,361,792 $ 185,170,340 
Long-term Capital Gains 1,512,242,418 140,213,056 
Total $1,982,604,210 $ 325,383,396 

 (a) For the period September 18, 2020 (commencement of operations) through June 30, 2021.

Restricted Securities (including Private Placements). Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities held at period end is included at the end of the Schedule of Investments, if applicable.

Commitments. A commitment is an agreement to acquire an investment at a future date (subject to conditions) in connection with a potential public or non-public offering. The amount of commitments outstanding at period end are presented in the table below. These commitments are not included in the net assets of the Fund at period end.

 Investment to be Acquired Commitment Amount 
Fidelity U.S. Equity Central Fund Twitter, Inc. $3,189,507 

Special Purpose Acquisition Companies. Funds may invest in stock, warrants, and other securities of special purpose acquisition companies (SPACs) or similar special purpose entities. A SPAC is a publicly traded company that raises investment capital via an initial public offering (IPO) for the purpose of acquiring the equity securities of one or more existing companies via merger, business combination, acquisition or other similar transactions within a designated time frame.

Private Investment in Public Equity. Funds may acquire equity securities of an issuer through a private investment in a public equity (PIPE) transaction, including through commitments to purchase securities on a when-issued basis. A PIPE typically involves the purchase of securities directly from a publicly traded company in a private placement transaction. Securities purchased through PIPE transactions will be restricted from trading and considered illiquid until a resale registration statement for the shares is filed and declared effective.

At the current and/or prior period end, the Fund had commitments to purchase when-issued securities through PIPE transactions with SPACs. The commitments are contingent upon the SPACs acquiring the securities of target companies. Unrealized appreciation (depreciation) on any commitments outstanding at period end is separately presented in the Statements of Assets and Liabilities as Unrealized appreciation (depreciation) on unfunded commitments, and any change in unrealized appreciation (depreciation) on unfunded commitments during the period is separately presented in the Statement of Operations, as applicable.

Consolidated Subsidiary. The Funds included in the table below hold certain investments through a wholly-owned subsidiary ("Subsidiary"), which may be subject to federal and state taxes upon disposition.

As of period end, investments in Subsidiaries were as follows:

 $ Amount % of Net Assets 
Fidelity U.S. Equity Central Fund 4,056,252 .02 

The financial statements have been consolidated to include the Subsidiary accounts where applicable. Accordingly, all inter-company transactions and balances have been eliminated.

At period end, any estimated tax liability for these investments is presented as "Deferred taxes" in the Statement of Assets and Liabilities and included in "Change in net unrealized appreciation (depreciation) on investment securities" in the Statement of Operations. The tax liability incurred may differ materially depending on conditions when these investments are disposed. Any cash held by a Subsidiary is restricted as to its use and is presented as "Restricted cash" in the Statement of Assets and Liabilities, if applicable.

4. Derivative Instruments.

Risk Exposures and the Use of Derivative Instruments. Investment objectives allow a fund to enter into various types of derivative contracts, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.

Derivatives were used to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the objectives may not be achieved.

Derivatives were used to increase or decrease exposure to the following risk(s):

Equity Risk Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.
 

Funds are also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that a fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to a fund. Exchange-traded contracts are not covered by the ISDA Master Agreement; however counterparty credit risk related to these contracts may be mitigated by the protection provided by the exchange on which they trade.

Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.

Futures Contracts. A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. Futures contracts were used to manage exposure to the stock market.

Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily and subsequent daily payments are made or received by a fund depending on the daily fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in daily variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.

Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end, and is representative of volume of activity during the period unless an average notional amount is presented. Any securities deposited to meet initial margin requirements are identified in the Schedule of Investments. Any cash deposited to meet initial margin requirements is presented as segregated cash with brokers for derivative instruments in the Statement of Assets and Liabilities.

5. Purchases and Sales of Investments.

Purchases and sales of securities, other than short-term securities and in-kind transactions, as applicable, are noted in the table below.

 Purchases ($) Sales ($) 
Fidelity U.S. Equity Central Fund 7,862,206,545 9,665,975,602 

6. Fees and Other Transactions with Affiliates.

Management Fee and Expense Contract. Fidelity Management & Research Company LLC (the investment adviser) provides the Fund with investment management services. The Fund does not pay any fees for these services. Pursuant to the Fund's management contract, the investment adviser receives a monthly management fee that represents a portion of the management fees it receives from the Investing Funds. In addition, under an expense contract, the investment adviser also pays all other expenses of the Fund, excluding custody fees, the compensation of the independent Directors, and certain miscellaneous expenses such as proxy and shareholder meeting expenses.

Brokerage Commissions. A portion of portfolio transactions were placed with brokerage firms which are affiliates of the investment adviser. Brokerage commissions are included in net realized gain (loss) and change in net unrealized appreciation (depreciation) in the Statement of Operations. The commissions paid to these affiliated firms were as follows:

 Amount 
Fidelity U.S. Equity Central Fund $168,579 

Interfund Lending Program. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (the SEC), the Fund, along with other registered investment companies having management contracts with FMR, or other affiliated entities of FMR, may participate in an interfund lending program. This program provides an alternative credit facility allowing the Fund to borrow from, or lend money to, other participating affiliated funds. At period end, there were no interfund loans outstanding. Activity in this program during the period for which loans were outstanding was as follows:

 Borrower or Lender Average Loan Balance Weighted Average Interest Rate Interest Expense 
Fidelity U.S. Equity Central Fund Borrower $144,159,000 1.06% $17,058 

Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Any interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note. Interfund trades during the period are noted in the table below.

 Purchases ($) Sales ($) Realized Gain (Loss) ($) 
Fidelity U.S. Equity Central Fund 549,877,195 653,434,057 66,944,061 

Affiliated Redemptions In-Kind. Shares that were redeemed in-kind for investments, including accrued interest and cash, if any, are shown in the table below. The net realized gain or loss on investments delivered through in-kind redemptions is included in the accompanying Statement of Operations. The amount of the in-kind redemptions is included in share transactions in the accompanying Statement of Changes in Net Assets. There was no gain or loss for federal income tax purposes.

 Shares Total net realized gain or loss
($) 
Total Proceeds
($) 
Fidelity U.S. Equity Central Fund 42,998,101 3,072,585,365 6,008,984,643 

Other. During the period, the investment adviser reimbursed the Fund for certain losses as follows:

 Amount ($) 
Fidelity U.S. Equity Central Fund 37,531 

7. Security Lending.

Funds lend portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the investment adviser. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of a fund's daily lending revenue, for its services as lending agent. A fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, a fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of a fund and any additional required collateral is delivered to a fund on the next business day. A fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, a fund may apply collateral received from the borrower against the obligation. A fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. Any loaned securities are identified as such in the Schedule of Investments, and the value of loaned securities and cash collateral at period end, as applicable, are presented in the Statement of Assets and Liabilities. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Statement of Operations as a component of income from Fidelity Central Funds. Affiliated security lending activity, if any, was as follows:

 Total Security Lending Fees Paid to NFS Security Lending Income From Securities Loaned to NFS Value of Securities Loaned to NFS at Period End 
Fidelity U.S. Equity Central Fund $94,523 $92,693 $765,930 

8. Other.

A fund's organizational documents provide former and current directors and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the fund. In the normal course of business, a fund may also enter into contracts that provide general indemnifications. A fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against a fund. The risk of material loss from such claims is considered remote.

At the end of the period, mutual funds managed by the investment adviser or its affiliates were the owners of record of all of the outstanding shares of the Fund.

9. Prior Fiscal Year Merger Information.

On September 18, 2020, the Fund acquired all of the assets and assumed all of the liabilities of each Target Fund listed in the below table pursuant to an Agreement and Plan of Reorganization approved by the Board of Trustees ("The Board"). The securities held by each Target Fund were the primary assets acquired by the Fund. Each acquisition was accomplished by an exchange of shares of the Fund for shares then outstanding of each Target Fund at their respective net asset value on the acquisition date. The reorganization provides shareholders of each Target Fund access to a larger portfolio with a similar investment objective and lower projected expenses. For financial reporting purposes, the assets and liabilities of each Target Fund and shares issued by the Fund were recorded at fair value; however, the cost basis of the investments received from each Target Fund were carried forward and will be utilized for purposes of the Fund's ongoing reporting of realized and unrealized gains and losses to more closely align subsequent reporting of realized gains with amounts distributable to shareholders for tax purposes. The reorganization qualified as a tax-free reorganization for federal income tax purposes with no gain or loss recognized to the funds or their shareholders.

Target Funds Securities $ Unrealized appreciation (depreciation) $ Net Assets $ Shares Exchanged Shares Exchanged Ratio 
Fidelity Communication Services Central Fund 2,141,812,833 519,302,172 2,120,801,164 21,208,011 2.404169 
Fidelity Consumer Discretionary Central Fund 2,379,545,185 1,008,679,474 2,377,079,793 23,770,800 4.114729 
Fidelity Consumer Staples Central Fund 1,404,755,423 183,109,941 1,408,546,669 14,085,469 2.173535 
Fidelity Energy Central Fund 492,966,055 (166,203,567) 492,316,660 4,923,164 .592504 
Fidelity Financials Central Fund 2,972,669,112 121,195,967 2,979,099,815 29,791,012 .892308 
Fidelity Health Care Central Fund 3,329,427,513 1,050,591,177 3,330,176,008 33,301,760 5.057539 
Fidelity Industrials Central Fund 1,767,416,176 475,772,074 1,769,747,563 17,697,476 2.866827 
Fidelity Information Technology Central Fund 6,093,403,752 2,363,995,847 6,085,657,837 60,856,583 5.380155 
Fidelity Materials Central Fund 509,207,518 93,756,573 509,656,880 5,096,569 2.038593 
Fidelity Utilities Central Fund 555,511,461 56,313,305 556,351,921 5,563,521 1.681890 

Surviving Fund Net assets $ Total net assets after the acquisition $ 
Fidelity U.S. Equity Central Fund 100 21,629,434,410 

Pro forma results of operations of the combined entity for the entire period ended June 30, 2021 as though the acquisition had occurred as of the beginning of the year (rather than on the actual acquisition date), are as follows:

Net investment income (loss) $285,180,268 
Total net realized gain (loss) 2,242,434,479 
Total change in net unrealized appreciation (depreciation) 6,315,625,250 
Net increase (decrease) in net assets resulting from operations $8,843,239,997 

Because the combined investment portfolios have been managed as a single portfolio since each acquisition was completed, it is not practicable to separate the amounts of revenue and earnings of each Target Fund that has been included in the Fund's Statement of Operations since September 18, 2020.

10. Coronavirus (COVID-19) Pandemic.

An outbreak of COVID-19 first detected in China during December 2019 has since spread globally and was declared a pandemic by the World Health Organization during March 2020. Developments that disrupt global economies and financial markets, such as the COVID-19 pandemic, may magnify factors that affect the Fund's performance.

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Fidelity Central Investment Portfolios LLC and the Shareholders of Fidelity U.S. Equity Central Fund

Opinion on the Financial Statements and Financial Highlights

We have audited the accompanying statement of assets and liabilities of Fidelity U.S. Equity Central Fund (the "Fund"), a fund of Fidelity Central Investment Portfolios LLC, including the schedule of investments, as of June 30, 2022, the related statement of operations for the year then ended, the statement of changes in net assets, and the financial highlights for the year then ended and for the period from September 18, 2020 (commencement of operations) through June 30, 2021, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of June 30, 2022, and the results of its operations for the year then ended, the changes in its net assets, and the financial highlights for the year then ended and for the period from September 18, 2020 (commencement of operations) through June 30, 2021, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements and financial highlights are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Fund is not required to have, nor were we engaged to perform, an audit of their internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of June 30, 2022, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

August 12, 2022


We have served as the auditor of one or more of the Fidelity investment companies since 1999.

Directors and Officers (Trustees and Officers)

The Trustees, Members of the Advisory Board (if any), and officers of the Fidelity Central Investment Portfolios LLC and fund, as applicable, are listed below. The Board of Trustees governs the fund and is responsible for protecting the interests of shareholders. The Trustees are experienced executives who meet periodically throughout the year to oversee the fund's activities, review contractual arrangements with companies that provide services to the fund, oversee management of the risks associated with such activities and contractual arrangements, and review the fund's performance.  Each of the Trustees oversees 316 funds. 

The Trustees hold office without limit in time except that (a) any Trustee may resign; (b) any Trustee may be removed by written instrument, signed by at least two-thirds of the number of Trustees prior to such removal; (c) any Trustee who requests to be retired or who has become incapacitated by illness or injury may be retired by written instrument signed by a majority of the other Trustees; and (d) any Trustee may be removed at any special meeting of shareholders by a two-thirds vote of the outstanding voting securities of the trust.  Each Trustee who is not an interested person (as defined in the 1940 Act) of the trust and the fund is referred to herein as an Independent Trustee.  Each Independent Trustee shall retire not later than the last day of the calendar year in which his or her 75th birthday occurs.  The Independent Trustees may waive this mandatory retirement age policy with respect to individual Trustees.  Officers and Advisory Board Members hold office without limit in time, except that any officer or Advisory Board Member may resign or may be removed by a vote of a majority of the Trustees at any regular meeting or any special meeting of the Trustees. Except as indicated, each individual has held the office shown or other offices in the same company for the past five years. 

The fund’s Statement of Additional Information (SAI) includes more information about the Trustees. To request a free copy, call Fidelity at 1-800-544-8544.

Experience, Skills, Attributes, and Qualifications of the Trustees. The Governance and Nominating Committee has adopted a statement of policy that describes the experience, qualifications, attributes, and skills that are necessary and desirable for potential Independent Trustee candidates (Statement of Policy). The Board believes that each Trustee satisfied at the time he or she was initially elected or appointed a Trustee, and continues to satisfy, the standards contemplated by the Statement of Policy. The Governance and Nominating Committee also engages professional search firms to help identify potential Independent Trustee candidates who have the experience, qualifications, attributes, and skills consistent with the Statement of Policy. From time to time, additional criteria based on the composition and skills of the current Independent Trustees, as well as experience or skills that may be appropriate in light of future changes to board composition, business conditions, and regulatory or other developments, have also been considered by the professional search firms and the Governance and Nominating Committee. In addition, the Board takes into account the Trustees' commitment and participation in Board and committee meetings, as well as their leadership of standing and ad hoc committees throughout their tenure.

In determining that a particular Trustee was and continues to be qualified to serve as a Trustee, the Board has considered a variety of criteria, none of which, in isolation, was controlling. The Board believes that, collectively, the Trustees have balanced and diverse experience, qualifications, attributes, and skills, which allow the Board to operate effectively in governing the fund and protecting the interests of shareholders. Information about the specific experience, skills, attributes, and qualifications of each Trustee, which in each case led to the Board's conclusion that the Trustee should serve (or continue to serve) as a trustee of the fund, is provided below.

Board Structure and Oversight Function. Robert A. Lawrence is an interested person and currently serves as Chair. The Trustees have determined that an interested Chair is appropriate and benefits shareholders because an interested Chair has a personal and professional stake in the quality and continuity of services provided to the fund. Independent Trustees exercise their informed business judgment to appoint an individual of their choosing to serve as Chair, regardless of whether the Trustee happens to be independent or a member of management. The Independent Trustees have determined that they can act independently and effectively without having an Independent Trustee serve as Chair and that a key structural component for assuring that they are in a position to do so is for the Independent Trustees to constitute a substantial majority for the Board. The Independent Trustees also regularly meet in executive session. David M. Thomas serves as Lead Independent Trustee and as such (i) acts as a liaison between the Independent Trustees and management with respect to matters important to the Independent Trustees and (ii) with management prepares agendas for Board meetings.

Fidelity® funds are overseen by different Boards of Trustees. The fund's Board oversees Fidelity's high income and certain equity funds, and other Boards oversee Fidelity's investment-grade bond, money market, asset allocation, and other equity funds. The asset allocation funds may invest in Fidelity® funds overseen by the fund's Board. The use of separate Boards, each with its own committee structure, allows the Trustees of each group of Fidelity® funds to focus on the unique issues of the funds they oversee, including common research, investment, and operational issues. On occasion, the separate Boards establish joint committees to address issues of overlapping consequences for the Fidelity® funds overseen by each Board.

The Trustees operate using a system of committees to facilitate the timely and efficient consideration of all matters of importance to the Trustees, the fund, and fund shareholders and to facilitate compliance with legal and regulatory requirements and oversight of the fund's activities and associated risks.  The Board, acting through its committees, has charged FMR and its affiliates with (i) identifying events or circumstances the occurrence of which could have demonstrably adverse effects on the fund's business and/or reputation; (ii) implementing processes and controls to lessen the possibility that such events or circumstances occur or to mitigate the effects of such events or circumstances if they do occur; and (iii) creating and maintaining a system designed to evaluate continuously business and market conditions in order to facilitate the identification and implementation processes described in (i) and (ii) above.  Because the day-to-day operations and activities of the fund are carried out by or through FMR, its affiliates, and other service providers, the fund's exposure to risks is mitigated but not eliminated by the processes overseen by the Trustees.  While each of the Board's committees has responsibility for overseeing different aspects of the fund's activities, oversight is exercised primarily through the Operations, Audit, and Compliance Committees.  Appropriate personnel, including but not limited to the fund's Chief Compliance Officer (CCO), FMR's internal auditor, the independent accountants, the fund's Treasurer and portfolio management personnel, make periodic reports to the Board's committees, as appropriate, including an annual review of Fidelity's risk management program for the Fidelity® funds.  The responsibilities of each standing committee, including their oversight responsibilities, are described further under "Standing Committees of the Trustees." 

Interested Trustees*:

Correspondence intended for a Trustee who is an interested person may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Bettina Doulton (1964)

Year of Election or Appointment: 2020

Trustee

Ms. Doulton also serves as Trustee of other Fidelity® funds. Prior to her retirement, Ms. Doulton served in a variety of positions at Fidelity Investments, including as a managing director of research (2006-2007), portfolio manager to certain Fidelity® funds (1993-2005), equity analyst and portfolio assistant (1990-1993), and research assistant (1987-1990). Ms. Doulton currently owns and operates Phi Builders + Architects and Cellardoor Winery. Previously, Ms. Doulton served as a member of the Board of Brown Capital Management, LLC (2014-2018).

Robert A. Lawrence (1952)

Year of Election or Appointment: 2020

Trustee

Chair of the Board of Trustees

Mr. Lawrence also serves as Trustee of other funds. Previously, Mr. Lawrence served as a Trustee and Member of the Advisory Board of certain funds. Prior to his retirement in 2008, Mr. Lawrence served as Vice President of certain Fidelity® funds (2006-2008), Senior Vice President, Head of High Income Division of Fidelity Management & Research Company (investment adviser firm, 2006-2008), and President of Fidelity Strategic Investments (investment adviser firm, 2002-2005).

 * Determined to be an “Interested Trustee” by virtue of, among other things, his or her affiliation with the Fidelity Central Investment Portfolios LLC or various entities under common control with FMR. 

 + The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund. 

Independent Trustees:

Correspondence intended for an Independent Trustee may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.

Name, Year of Birth; Principal Occupations and Other Relevant Experience+

Thomas P. Bostick (1956)

Year of Election or Appointment: 2021

Trustee

Lieutenant General Bostick also serves as Trustee of other Fidelity® funds. Prior to his retirement, General Bostick (United States Army, Retired) held a variety of positions within the U.S. Army, including Commanding General and Chief of Engineers, U.S. Army Corps of Engineers (2012-2016) and Deputy Chief of Staff and Director of Human Resources, U.S. Army (2009-2012). General Bostick currently serves as a member of the Board and Finance and Governance Committees of CSX Corporation (transportation, 2020-present) and a member of the Board and Corporate Governance and Nominating Committee of Perma-Fix Environmental Services, Inc. (nuclear waste management, 2020-present). General Bostick serves as Chief Executive Officer of Bostick Global Strategies, LLC (consulting, 2016-present) and as a member of the Board of HireVue, Inc. (video interview and assessment, 2020-present). Previously, General Bostick served as a Member of the Advisory Board of certain Fidelity® funds (2021), President, Intrexon Bioengineering (2018-2020) and Chief Operating Officer (2017-2020) and Senior Vice President of the Environment Sector (2016-2017) of Intrexon Corporation (biopharmaceutical company).

Dennis J. Dirks (1948)

Year of Election or Appointment: 2005

Trustee

Mr. Dirks also serves as Trustee of other Fidelity® funds. Prior to his retirement in May 2003, Mr. Dirks served as Chief Operating Officer and as a member of the Board of The Depository Trust & Clearing Corporation (financial markets infrastructure), President, Chief Operating Officer and a member of the Board of The Depository Trust Company (DTC), President and a member of the Board of the National Securities Clearing Corporation (NSCC), Chief Executive Officer and a member of the Board of the Government Securities Clearing Corporation and Chief Executive Officer and a member of the Board of the Mortgage-Backed Securities Clearing Corporation. Mr. Dirks currently serves as a member of the Finance Committee (2016-present) and Board (2017-present) and is Treasurer (2018-present) of the Asolo Repertory Theatre.

Donald F. Donahue (1950)

Year of Election or Appointment: 2018

Trustee

Mr. Donahue also serves as Trustee of other Fidelity® funds. Mr. Donahue serves as President and Chief Executive Officer of Miranda Partners, LLC (risk consulting for the financial services industry, 2012-present). Previously, Mr. Donahue served as Chief Executive Officer (2006-2012), Chief Operating Officer (2003-2006) and Managing Director, Customer Marketing and Development (1999-2003) of The Depository Trust & Clearing Corporation (financial markets infrastructure). Mr. Donahue currently serves as a member (2007-present) and Co-Chairman (2016-present) of the Board of United Way of New York and a member of the Board of The Leadership Academy (previously NYC Leadership Academy) (2012-present). Mr. Donahue previously served as a member of the Advisory Board of certain Fidelity® funds (2015-2018).

Vicki L. Fuller (1957)

Year of Election or Appointment: 2020

Trustee

Ms. Fuller also serves as Trustee of other Fidelity® funds. Previously, Ms. Fuller served as a member of the Advisory Board of certain Fidelity® funds (2018-2020), Chief Investment Officer of the New York State Common Retirement Fund (2012-2018) and held a variety of positions at AllianceBernstein L.P. (global asset management, 1985-2012), including Managing Director (2006-2012) and Senior Vice President and Senior Portfolio Manager (2001-2006). Ms. Fuller currently serves as a member of the Board, Audit Committee and Nominating and Governance Committee of two Blackstone business development companies (2020-present), as a member of the Board of Treliant, LLC (consulting, 2019-present), as a member of the Advisory Board of Ariel Alternatives, LLC (private equity, 2021-present) and as a member of the Board and Chair of the Audit Committee of Gusto, Inc. (software, 2021-present). In addition, Ms. Fuller currently serves as a member of the Board of Roosevelt University (2019-present) and as a member of the Executive Board of New York University’s Stern School of Business. Ms. Fuller previously served as a member of the Board, Audit Committee and Nominating and Governance Committee of The Williams Companies, Inc. (natural gas infrastructure, 2018-2021).

Patricia L. Kampling (1959)

Year of Election or Appointment: 2020

Trustee

Ms. Kampling also serves as Trustee of other Fidelity® funds. Prior to her retirement, Ms. Kampling served as Chairman of the Board and Chief Executive Officer (2012-2019), President and Chief Operating Officer (2011-2012) and Executive Vice President and Chief Financial Officer (2010-2011) of Alliant Energy Corporation. Ms. Kampling currently serves as a member of the Board, Finance Committee and Governance, Compensation and Nominating Committee of Xcel Energy Inc. (utilities company, 2020-present) and as a member of the Board, Audit, Finance and Risk Committee and Safety, Environmental, Technology and Operations Committee and Chair of the Executive Development and Compensation Committee of American Water Works Company, Inc. (utilities company, 2019-present). In addition, Ms. Kampling currently serves as a member of the Board of the Nature Conservancy, Wisconsin Chapter (2019-present). Previously, Ms. Kampling served as a Member of the Advisory Board of certain Fidelity® funds (2020), a member of the Board, Compensation Committee and Executive Committee and Chair of the Audit Committee of Briggs & Stratton Corporation (manufacturing, 2011-2021), a member of the Board of Interstate Power and Light Company (2012-2019) and Wisconsin Power and Light Company (2012-2019) (each a subsidiary of Alliant Energy Corporation) and as a member of the Board and Workforce Development Committee of the Business Roundtable (2018-2019).

Thomas A. Kennedy (1955)

Year of Election or Appointment: 2021

Trustee

Mr. Kennedy also serves as Trustee of other Fidelity® funds. Previously, Mr. Kennedy served as a Member of the Advisory Board of certain Fidelity® funds (2020) and held a variety of positions at Raytheon Company (aerospace and defense, 1983-2020), including Chairman and Chief Executive Officer (2014-2020) and Executive Vice President and Chief Operating Officer (2013-2014). Mr. Kennedy currently serves as Executive Chairman of the Board of Directors of Raytheon Technologies Corporation (aerospace and defense, 2020-present). He is also a member of the Rutgers School of Engineering Industry Advisory Board (2011-present) and a member of the UCLA Engineering Dean’s Executive Board (2016-present).

Oscar Munoz (1959)

Year of Election or Appointment: 2021

Trustee

Mr. Munoz also serves as Trustee of other Fidelity® funds. Prior to his retirement, Mr. Munoz served as Executive Chairman (2020-2021), Chief Executive Officer (2015-2020), President (2015-2016) and a member of the Board (2010-2021) of United Airlines Holdings, Inc. Mr. Munoz currently serves as a member of the Board of CBRE Group, Inc. (commercial real estate, 2020-present), a member of the Board of Univision Communications, Inc. (Hispanic media, 2020-present) and a member of the Advisory Board of Salesforce.com, Inc. (cloud-based software, 2020-present). Previously, Mr. Munoz served as a Member of the Advisory Board of certain Fidelity® funds (2021).

Garnett A. Smith (1947)

Year of Election or Appointment: 2018

Trustee

Mr. Smith also serves as Trustee of other Fidelity® funds. Prior to his retirement, Mr. Smith served as Chairman and Chief Executive Officer (1990-1997) and President (1986-1990) of Inbrand Corp. (manufacturer of personal absorbent products). Prior to his employment with Inbrand Corp., he was employed by a retail fabric chain and North Carolina National Bank (now Bank of America). Mr. Smith previously served as a member of the Advisory Board of certain Fidelity® funds (2012-2013).

David M. Thomas (1949)

Year of Election or Appointment: 2008

Trustee

Lead Independent Trustee

Mr. Thomas also serves as Trustee of other Fidelity® funds. Previously, Mr. Thomas served as Executive Chairman (2005-2006) and Chairman and Chief Executive Officer (2000-2005) of IMS Health, Inc. (pharmaceutical and healthcare information solutions). Mr. Thomas currently serves as a member of the Board of Fortune Brands Home and Security (home and security products, 2004-present) and as Director (2013-present) and Non-Executive Chairman of the Board (2022-present) of Interpublic Group of Companies, Inc. (marketing communication).

Susan Tomasky (1953)

Year of Election or Appointment: 2020

Trustee

Ms. Tomasky also serves as Trustee of other Fidelity® funds. Prior to her retirement, Ms. Tomasky served in various executive officer positions at American Electric Power Company, Inc. (1998-2011), including most recently as President of AEP Transmission (2007-2011). Ms. Tomasky currently serves as a member of the Board and Sustainability Committee and as Chair of the Audit Committee of Marathon Petroleum Corporation (2018-present) and as a member of the Board, Executive Committee, Corporate Governance Committee and Organization and Compensation Committee and as Chair of the Audit Committee of Public Service Enterprise Group, Inc. (utilities company, 2012-present) and as a member of the Board of its subsidiary company, Public Service Electric and Gas Co. (2021-present). In addition, Ms. Tomasky currently serves as a member (2009-present) and President (2020-present) of the Board of the Royal Shakespeare Company – America (2009-present), as a member of the Board of the Columbus Association for the Performing Arts (2011-present) and as a member of the Board and Kenyon in the World Committee of Kenyon College (2016-present). Previously, Ms. Tomasky served as a Member of the Advisory Board of certain Fidelity® funds (2020), as a member of the Board of the Columbus Regional Airport Authority (2007-2020), as a member of the Board (2011-2018) and Lead Independent Director (2015-2018) of Andeavor Corporation (previously Tesoro Corporation) (independent oil refiner and marketer) and as a member of the Board of Summit Midstream Partners LP (energy, 2012-2018).

Michael E. Wiley (1950)

Year of Election or Appointment: 2018

Trustee

Mr. Wiley also serves as Trustee of other Fidelity® funds. Previously, Mr. Wiley served as a member of the Advisory Board of certain Fidelity® funds (2018-2020), Chairman, President and CEO of Baker Hughes, Inc. (oilfield services, 2000-2004). Mr. Wiley also previously served as a member of the Board of Andeavor Corporation (independent oil refiner and marketer, 2005-2018), a member of the Board of Andeavor Logistics LP (natural resources logistics, 2015-2018) and a member of the Board of High Point Resources (exploration and production, 2005-2020).

 + The information includes the Trustee's principal occupation during the last five years and other information relating to the experience, attributes, and skills relevant to the Trustee's qualifications to serve as a Trustee, which led to the conclusion that the Trustee should serve as a Trustee for the fund. 

Advisory Board Members and Officers:

Correspondence intended for a Member of the Advisory Board (if any) may be sent to Fidelity Investments, P.O. Box 55235, Boston, Massachusetts 02205-5235.  Correspondence intended for an officer or Peter S. Lynch may be sent to Fidelity Investments, 245 Summer Street, Boston, Massachusetts 02210.  Officers appear below in alphabetical order. 

Name, Year of Birth; Principal Occupation

Peter S. Lynch (1944)

Year of Election or Appointment: 2004

Member of the Advisory Board

Mr. Lynch also serves as a Member of the Advisory Board of other Fidelity® funds. Mr. Lynch is Vice Chairman and a Director of Fidelity Management & Research Company LLC (investment adviser firm). In addition, Mr. Lynch serves as a Trustee of Boston College and as the Chairman of the Inner-City Scholarship Fund. Previously, Mr. Lynch served as Vice Chairman and a Director of FMR Co., Inc. (investment adviser firm) and on the Special Olympics International Board of Directors (1997-2006).

Craig S. Brown (1977)

Year of Election or Appointment: 2019

Assistant Treasurer

Mr. Brown also serves as an officer of other funds. Mr. Brown serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2013-present).

John J. Burke III (1964)

Year of Election or Appointment: 2018

Chief Financial Officer

Mr. Burke also serves as Chief Financial Officer of other funds. Mr. Burke serves as Head of Investment Operations for Fidelity Fund and Investment Operations (2018-present) and is an employee of Fidelity Investments (1998-present). Previously Mr. Burke served as head of Asset Management Investment Operations (2012-2018).

William C. Coffey (1969)

Year of Election or Appointment: 2019

Assistant Secretary

Mr. Coffey also serves as Assistant Secretary of other funds. He is Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2010-present), and is an employee of Fidelity Investments. Previously, Mr. Coffey served as Secretary and CLO of certain funds (2018-2019); CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company and FMR Co., Inc. (investment adviser firms, 2018-2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2018-2019); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2018-2019); and Assistant Secretary of certain funds (2009-2018).

Timothy M. Cohen (1969)

Year of Election or Appointment: 2018

Vice President

Mr. Cohen also serves as Vice President of other funds. Mr. Cohen serves as Co-Head of Equity (2018-present), a Director of Fidelity Management & Research (Japan) Limited (investment adviser firm, 2016-present), and is an employee of Fidelity Investments. Previously, Mr. Cohen served as Executive Vice President of Fidelity SelectCo, LLC (2019), Head of Global Equity Research (2016-2018), Chief Investment Officer - Equity and a Director of Fidelity Management & Research (U.K.) Inc. (investment adviser firm, 2013-2015) and as a Director of Fidelity Management & Research (Hong Kong) Limited (investment adviser firm, 2017).

Jonathan Davis (1968)

Year of Election or Appointment: 2010

Assistant Treasurer

Mr. Davis also serves as an officer of other funds. Mr. Davis serves as Assistant Treasurer of FIMM, LLC (2021-present), FMR Capital, Inc. (2017-present), FD Funds GP LLC (2021-present), FD Funds Holding LLC (2021-present), and FD Funds Management LLC (2021-present); and is an employee of Fidelity Investments. Previously, Mr. Davis served as Vice President and Associate General Counsel of FMR LLC (diversified financial services company, 2003-2010).

Laura M. Del Prato (1964)

Year of Election or Appointment: 2018

Assistant Treasurer

Ms. Del Prato also serves as an officer of other funds. Ms. Del Prato serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2017-present). Previously, Ms. Del Prato served as President and Treasurer of The North Carolina Capital Management Trust: Cash Portfolio and Term Portfolio (2018-2020). Prior to joining Fidelity Investments, Ms. Del Prato served as a Managing Director and Treasurer of the JPMorgan Mutual Funds (2014-2017). Prior to JPMorgan, Ms. Del Prato served as a partner at Cohen Fund Audit Services (accounting firm, 2012-2013) and KPMG LLP (accounting firm, 2004-2012).

Colm A. Hogan (1973)

Year of Election or Appointment: 2020

Assistant Treasurer

Mr. Hogan also serves as an officer of other funds. Mr. Hogan serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present) and is an employee of Fidelity Investments (2005-present). Previously, Mr. Hogan served as Deputy Treasurer of certain Fidelity® funds (2016-2020) and Assistant Treasurer of certain Fidelity® funds (2016-2018). 

Pamela R. Holding (1964)

Year of Election or Appointment: 2018

Vice President

Ms. Holding also serves as Vice President of other funds. Ms. Holding serves as Co-Head of Equity (2018-present) and is an employee of Fidelity Investments (2013-present). Previously, Ms. Holding served as Executive Vice President of Fidelity SelectCo, LLC (2019) and as Chief Investment Officer of Fidelity Institutional Asset Management (2013-2018).

Cynthia Lo Bessette (1969)

Year of Election or Appointment: 2019

Secretary and Chief Legal Officer (CLO)

Ms. Lo Bessette also serves as an officer of other funds. Ms. Lo Bessette serves as CLO, Secretary, and Senior Vice President of Fidelity Management & Research Company LLC (investment adviser firm, 2019-present); CLO of Fidelity Management & Research (Hong Kong) Limited, FMR Investment Management (UK) Limited, and Fidelity Management & Research (Japan) Limited (investment adviser firms, 2019-present); Secretary of FD Funds GP LLC (2021-present), FD Funds Holding LLC (2021-present), and FD Funds Management LLC (2021-present); and Assistant Secretary of FIMM, LLC (2019-present). She is a Senior Vice President and Deputy General Counsel of FMR LLC (diversified financial services company, 2019-present), and is an employee of Fidelity Investments. Previously, Ms. Lo Bessette served as CLO, Secretary, and Senior Vice President of FMR Co., Inc. (investment adviser firm, 2019); Secretary of Fidelity SelectCo, LLC and Fidelity Investments Money Management, Inc. (investment adviser firms, 2019). Prior to joining Fidelity Investments, Ms. Lo Bessette was Executive Vice President, General Counsel (2016-2019) and Senior Vice President, Deputy General Counsel (2015-2016) of OppenheimerFunds (investment management company) and Deputy Chief Legal Officer (2013-2015) of Jennison Associates LLC (investment adviser firm).

Chris Maher (1972)

Year of Election or Appointment: 2020

Deputy Treasurer

Mr. Maher also serves as an officer of other funds. Mr. Maher serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present), and is an employee of Fidelity Investments (2008-present). Previously, Mr. Maher served as Assistant Treasurer of certain funds (2013-2020); Vice President of Asset Management Compliance (2013), Vice President of the Program Management Group of FMR (investment adviser firm, 2010-2013), and Vice President of Valuation Oversight (2008-2010).

Jason P. Pogorelec (1975)

Year of Election or Appointment: 2020

Chief Compliance Officer

Mr. Pogorelec also serves as Chief Compliance Officer of other funds. Mr. Pogorelec is a senior Vice President of Asset Management Compliance for Fidelity Investments and is an employee of Fidelity Investments (2006-present). Previously, Mr. Pogorelec served as Vice President, Associate General Counsel for Fidelity Investments (2010-2020) and Assistant Secretary of certain Fidelity funds (2015-2020).

Brett Segaloff (1972)

Year of Election or Appointment: 2021

Anti-Money Laundering (AML) Officer

Mr. Segaloff also serves as an AML Officer of other funds and other related entities. He is Director, Anti-Money Laundering (2007-present) of FMR LLC (diversified financial services company) and is an employee of Fidelity Investments (1996-present).

Stacie M. Smith (1974)

Year of Election or Appointment: 2016

President and Treasurer

Ms. Smith also serves as an officer of other funds. Ms. Smith serves as Assistant Treasurer of FIMM, LLC (2021-present) and FMR Capital, Inc. (2017-present), is an employee of Fidelity Investments (2009-present), and has served in other fund officer roles. Prior to joining Fidelity Investments, Ms. Smith served as Senior Audit Manager of Ernst & Young LLP (accounting firm, 1996-2009). Previously, Ms. Smith served as Assistant Treasurer (2013-2019) and Deputy Treasurer (2013-2016) of certain Fidelity® funds.

Jim Wegmann (1979)

Year of Election or Appointment: 2019

Assistant Treasurer

Mr. Wegmann also serves as an officer of other funds. Mr. Wegmann serves as Assistant Treasurer of FIMM, LLC (2021-present) and is an employee of Fidelity Investments (2011-present). Previously, Mr. Wegmann served as Assistant Treasurer of certain Fidelity® funds (2019-2021).

Shareholder Expense Example

As a shareholder, you incur two types of costs: (1) transaction costs, which may include sales charges (loads) on purchase payments or redemption proceeds, as applicable and (2) ongoing costs, which generally include management fees, distribution and/or service (12b-1) fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (January 1, 2022 to June 30, 2022).

Actual Expenses

The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line for a class/Fund under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. If any fund is a shareholder of any underlying mutual funds or exchange-traded funds (ETFs) (the Underlying Funds), such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses incurred presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.

Hypothetical Example for Comparison Purposes

The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. If any fund is a shareholder of any Underlying Funds, such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses as presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 Annualized Expense Ratio-A Beginning
Account Value
January 1, 2022 
Ending
Account Value
June 30, 2022 
Expenses Paid
During Period-B
January 1, 2022
to June 30, 2022 
Fidelity U.S. Equity Central Fund .0012%    
Actual  $1,000.00 $782.70 $.01 
Hypothetical-C  $1,000.00 $1,024.79 $.01 

 A Annualized expense ratio reflects expenses net of applicable fee waivers.

 B Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/ 365 (to reflect the one-half year period). The fees and expenses of any Underlying Funds are not included in each annualized expense ratio.

 C 5% return per year before expenses

Distributions (Unaudited)

The dividend and capital gains distributions for the fund(s) are available on Fidelity.com or Institutional.Fidelity.com.

The fund hereby designates as a capital gain dividend with respect to the taxable year ended June 30, 2022, $ 1,346,292,580, or, if subsequently determined to be different, the net capital gain of such year.

A total of 0.02% of the dividends distributed during the fiscal year was derived from interest on U.S. Government securities which is generally exempt from state income tax.

The fund designates 100% of the short-term capital gain dividends distributed in December during the fiscal year as qualifying to be taxed as short-term capital gain dividends for nonresident alien shareholders.

The fund designates 0%, 37%, 100%, and 100% of the dividends distributed in September, December, March, and June, respectively during the fiscal year as qualifying for the dividends–received deduction for corporate shareholders.

The fund designates 7%, 44%, 100%, and 100% of the dividends distributed in September, December, March, and June, respectively during the fiscal year as amounts which may be taken into account as a dividend for the purposes of the maximum rate under section 1(h)(11) of the Internal Revenue Code.

The fund designates 7%, 7%, 0%, and 0% of the dividends distributed in September, December, March, and June, respectively during the fiscal year as a section 199A dividend.

The fund will notify shareholders in January 2023 of amounts for use in preparing 2022 income tax returns.

Board Approval of Investment Advisory Contracts and Management Fees

Fidelity U.S. Equity Central Fund

Each year, the Board of Directors, including the Independent Directors (together, the Board), votes on the renewal of the management contract with Fidelity Management & Research Company LLC (FMR) and the sub-advisory agreements (together, the Advisory Contracts) for the fund. FMR and the sub-advisers are referred to herein as the Investment Advisers. The Board, assisted by the advice of fund counsel and Independent Directors' counsel, requests and considers a broad range of information relevant to the renewal of the Advisory Contracts throughout the year.

The Board meets regularly and, at each of its meetings, covers an extensive agenda of topics and materials and considers factors that are relevant to its annual consideration of the renewal of the fund's Advisory Contracts, including the services and support provided to the fund and its shareholders. The Board has established various standing committees (Committees), each composed of and chaired by Independent Directors with varying backgrounds, to which the Board has assigned specific subject matter responsibilities in order to enhance effective decision-making by the Board. The Board, acting directly and through its Committees, requests and receives information concerning the annual consideration of the renewal of the fund's Advisory Contracts. The Board also meets as needed to review matters specifically related to the Board's annual consideration of the renewal of the Advisory Contracts. Members of the Board may also meet with trustees of other Fidelity funds through joint ad hoc committees to discuss certain matters relevant to all of the Fidelity funds.

At its May 2022 meeting, the Board unanimously determined to renew the fund's Advisory Contracts. In reaching its determination, the Board considered all factors it believed relevant and reached a determination, with the assistance of fund counsel and Independent Directors' counsel and through the exercise of its business judgment, that the renewal of the Advisory Contracts was in the best interests of the fund and its shareholders and the fact that no fee is payable under the management contract was fair and reasonable.

Nature, Extent, and Quality of Services Provided.  The Board considered Fidelity's staffing as it relates to the fund, including the backgrounds of investment personnel of Fidelity, and also considered the fund's investment objective, strategies, and related investment philosophy. The Independent Directors also had discussions with senior management of Fidelity's investment operations and investment groups. The Board considered the structure of the investment personnel compensation program and whether this structure provides appropriate incentives to act in the best interests of the fund. The Board also considered the steps Fidelity had taken to ensure the continued provision of high quality services to the Fidelity funds during the COVID-19 pandemic, including the expansion of staff in client facing positions to maintain service levels in periods of high volumes and volatility.

Resources Dedicated to Investment Management and Support Services.  The Board and the Fund Oversight and Research Committees reviewed the general qualifications and capabilities of Fidelity's investment staff, including its size, education, experience, and resources, as well as Fidelity's approach to recruiting, training, managing, and compensating investment personnel. The Board noted the resources devoted to expansion of Fidelity's global investment organization, and that Fidelity's analysts have extensive resources, tools, and capabilities that allow them to conduct sophisticated quantitative and fundamental analysis, as well as credit analysis of issuers, counterparties, and guarantors. Further, the Board considered that Fidelity's investment professionals have sufficient access to global information and data so as to provide competitive investment results over time, and that those professionals also have access to sophisticated tools that permit them to assess portfolio construction and risk and performance attribution characteristics continuously, as well as to transmit new information and research conclusions rapidly around the world. Additionally, in its deliberations, the Board considered Fidelity's trading, risk management, compliance, and technology and operations capabilities and resources, which are integral parts of the investment management process.

Administrative Services.  The Board considered (i) the nature, extent, quality, and cost of advisory and administrative services performed by the Investment Advisers and their affiliates under the Advisory Contracts and under separate agreements covering transfer agency, pricing and bookkeeping, and securities lending services for the fund; (ii) the nature and extent of the supervision of third party service providers, principally custodians, subcustodians, and pricing vendors; and (iii) the resources devoted to, and the record of compliance with, the fund's compliance policies and procedures. The Board also reviewed the allocation of fund brokerage, including allocations to brokers affiliated with the Investment Advisers, and the use of "soft" commission dollars to pay for research services.

Investment Performance.  The Board considered whether the fund has operated in accordance with its investment objective, as well as its record of compliance with its investment restrictions. The Board reviewed the fund's absolute investment performance, as well as the fund's relative investment performance, but did not consider performance to be a material factor in its decision to renew the fund's Advisory Contracts, as the fund is not publicly offered as a stand-alone investment product. In this regard, the Board noted that the fund is designed to offer a liquid investment option for other investment companies managed by Fidelity and ultimately to enhance the performance of those investment companies.

Based on its review, the Board concluded that the nature, extent, and quality of services provided to the fund under the Advisory Contracts should continue to benefit the shareholders of the fund.

Competitiveness of Management Fee and Total Expense Ratio.  The Board considered that while the fund does not pay a management fee, FMR receives fees for providing services to funds that invest in the fund. The Board also noted that FMR bears all expenses of the fund with certain limited exceptions (i.e., custody fees, interest, taxes, fees and expenses of the Independent Trustees, proxy and shareholder meeting expenses, and extraordinary expenses). The Board further noted that the fund pays its non-operating expenses, including brokerage commissions and fees and expenses associated with the fund's securities lending program, if applicable. Based on its review, the Board concluded that the management fee received for providing services to the fund and the fund's total expense ratio were reasonable in light of the services that the fund and its shareholders receive and the other factors considered.

Costs of the Services and Profitability.  The Board considered the level of Fidelity's profits in respect of all the Fidelity funds, as well as the profitability of the funds that invest in the fund.

A public accounting firm has been engaged annually by the Board as part of the Board's assessment of Fidelity's profitability analysis. The engagement includes the review and assessment of the methodologies used by Fidelity in determining the revenues and expenses attributable to Fidelity's mutual fund business, and completion of agreed-upon procedures in respect of the mathematical accuracy of certain fund profitability information and its conformity to established allocation methodologies. After considering the reports issued under the engagement and information provided by Fidelity, the Board concluded that while other allocation methods may also be reasonable, Fidelity's profitability methodologies are reasonable in all material respects.

The Board also reviewed Fidelity's non-fund businesses and potential indirect benefits such businesses may have received as a result of their association with Fidelity's mutual fund business (i.e., fall-out benefits) as well as cases where Fidelity's affiliates may benefit from the funds' business. The Board considered areas where potential indirect benefits to the Fidelity funds from their relationships with Fidelity may exist. The Board's consideration of these matters was informed by the findings of a joint ad hoc committee created by it and the boards of other Fidelity funds to evaluate potential fall-out benefits.

The Board concluded that the costs of the services provided by and the profits realized by Fidelity in connection with the operation of the fund were not relevant to the renewal of the Advisory Contracts because the fund pays no advisory fees and FMR bears all expenses of the fund with certain exceptions.

Economies of Scale.  The Board concluded that because the fund pays no advisory fees and FMR bears all expenses of the fund with certain exceptions, the realization of economies of scale was not a material factor in the Board's decision to renew the fund's Advisory Contract.

Additional Information Requested by the Board.  In order to develop fully the factual basis for consideration of the Fidelity funds' advisory contracts, the Board requested and received additional information on certain topics, including: (i) fund flow and performance trends, in particular the underperformance of certain funds and strategies, and Fidelity's long-term strategies for certain funds, including any consideration of fund liquidations or mergers; (ii) the operation of performance fees, competitor use of performance fees, and consideration of the expansion of performance fees to additional funds; (iii) Fidelity's pricing philosophy compared to competitors; (iv) fund profitability methodology and data; (v) evaluation of competitive fund data and peer group classifications and fee and expense comparisons; (vi) the management fee and expense structures for different funds and classes and information about the differences between various fee and expense structures; (vii) group fee breakpoints and related voluntary fee waivers; and (viii) information regarding other accounts managed by Fidelity and the funds' sub-advisory arrangements.

Based on its evaluation of all of the conclusions noted above, and after considering all factors it believed relevant, the Board concluded that the advisory fee arrangements are fair and reasonable, and that the fund's Advisory Contracts should be renewed.

Liquidity Risk Management Program

The Securities and Exchange Commission adopted Rule 22e-4 under the Investment Company Act of 1940 (the Liquidity Rule) to promote effective liquidity risk management throughout the open-end investment company industry, thereby reducing the risk that funds will be unable to meet their redemption obligations and mitigating dilution of the interests of fund shareholders.

The Fund has adopted and implemented a liquidity risk management program pursuant to the Liquidity Rule (the Program) effective December 1, 2018. The Program is reasonably designed to assess and manage the Fund’s liquidity risk and to comply with the requirements of the Liquidity Rule. The Fund’s Board of Trustees (the Board) has designated the Fund’s investment adviser as administrator of the Program. The Fidelity advisers have established a Liquidity Risk Management Committee (the LRM Committee) to manage the Program for each of the Fidelity Funds. The LRM Committee monitors the adequacy and effectiveness of implementation of the Program and on a periodic basis assesses each Fund’s liquidity risk based on a variety of factors including (1) the Fund’s investment strategy, (2) portfolio liquidity and cash flow projections during normal and reasonably foreseeable stressed conditions, (3) shareholder redemptions, (4) borrowings and other funding sources and (5) in the case of exchange-traded funds, certain additional factors including the effect of the Fund’s prices and spreads, market participants, and basket compositions on the overall liquidity of the Fund’s portfolio, as applicable.

In accordance with the Program, each of the Fund’s portfolio investments is classified into one of four liquidity categories described below based on a determination of a reasonable expectation for how long it would take to convert the investment to cash (or sell or dispose of the investment) without significantly changing its market value.

  • Highly liquid investments – cash or convertible to cash within three business days or less
  • Moderately liquid investments – convertible to cash in three to seven calendar days
  • Less liquid investments – can be sold or disposed of, but not settled, within seven calendar days
  • Illiquid investments – cannot be sold or disposed of within seven calendar days

Liquidity classification determinations take into account a variety of factors including various market, trading and investment-specific considerations, as well as market depth, and generally utilize analysis from a third-party liquidity metrics service.

The Liquidity Rule places a 15% limit on a fund’s illiquid investments and requires funds that do not primarily hold assets that are highly liquid investments to determine and maintain a minimum percentage of the fund’s net assets to be invested in highly liquid investments (highly liquid investment minimum or HLIM). The Program includes provisions reasonably designed to comply with the 15% limit on illiquid investments and for determining, periodically reviewing and complying with the HLIM requirement as applicable.

At a recent meeting of the Fund’s Board of Trustees, the LRM Committee provided a written report to the Board pertaining to the operation, adequacy, and effectiveness of implementation of the Program for the annual period from December 1, 2020 through November 30, 2021. The report concluded that the Program has been implemented and is operating effectively and is reasonably designed to assess and manage the Fund’s liquidity risk.





Fidelity Investments

USE-ANN-0822
1.9900193.101


Item 2.

Code of Ethics


As of the end of the period, June 30, 2022, Fidelity Central Investment Portfolios LLC (the trust) has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its President and Treasurer and its Chief Financial Officer.  A copy of the code of ethics is filed as an exhibit to this Form N-CSR.


Item 3.

Audit Committee Financial Expert


The Board of Trustees of the trust has determined that Donald F. Donahue is an audit committee financial expert, as defined in Item 3 of Form N-CSR.  Mr. Donahue is independent for purposes of Item 3 of Form N-CSR.  



Item 4.  

Principal Accountant Fees and Services


Fees and Services


The following table presents fees billed by Deloitte & Touche LLP, the member firms of Deloitte Touche Tohmatsu, and their respective affiliates (collectively, Deloitte Entities) in each of the last two fiscal years for services rendered to Fidelity U.S. Equity Central Fund (the Fund):


Services Billed by Deloitte Entities


June 30, 2022 FeesA


Audit Fees

Audit-Related Fees

Tax Fees

All Other Fees

Fidelity U.S. Equity Central Fund

$46,700

                            $-   

$9,900

$1,000



June 30, 2021 FeesA


Audit Fees

Audit-Related Fees

Tax Fees

All Other Fees

Fidelity U.S. Equity Central Fund

 $38,100  

$-

 $7,000

$700



A Amounts may reflect rounding.


The following table(s) present(s) fees billed by Deloitte Entities that were required to be approved by the Audit Committee for services that relate directly to the operations and financial reporting of the Fund(s) and that are rendered on behalf of Fidelity Management & Research Company LLC ("FMR") and entities controlling, controlled by, or under common control with FMR (not including any sub-adviser whose role is primarily



portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund(s) (Fund Service Providers):



Services Billed by Deloitte Entities




June 30, 2022A

June 30, 2021 A

Audit-Related Fees

$-

$-

Tax Fees

$-

$-

All Other Fees

$-

$-


A Amounts may reflect rounding.

Audit-Related Fees represent fees billed for assurance and related services that are reasonably related to the performance of the fund audit or the review of the fund's financial statements and that are not reported under Audit Fees.


Tax Fees represent fees billed for tax compliance, tax advice or tax planning that relate directly to the operations and financial reporting of the fund.


All Other Fees represent fees billed for services provided to the fund or Fund Service Provider, a significant portion of which are assurance related, that relate directly to the operations and financial reporting of the fund, excluding those services that are reported under Audit Fees, Audit-Related Fees or Tax Fees.  


Assurance services must be performed by an independent public accountant.


* * *


The aggregate non-audit fees billed by Deloitte Entities for services rendered to the Fund(s), FMR (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any Fund Service Provider for each of the last two fiscal years of the Fund(s) are as follows:




Billed By

June 30, 2022A

June 30, 2021A

Deloitte Entities

$468,500

$529,300




 

A Amounts may reflect rounding.



The trust's Audit Committee has considered non-audit services that were not pre-approved that were provided by Deloitte Entities to Fund Service Providers to be



compatible with maintaining the independence of Deloitte Entities in its(their) audit of the Fund(s), taking into account representations from Deloitte Entities, in accordance with Public Company Accounting Oversight Board rules, regarding its independence from the Fund(s) and its(their) related entities and FMRs review of the appropriateness and permissibility under applicable law of such non-audit services prior to their provision to the Fund(s) Service Providers.


Audit Committee Pre-Approval Policies and Procedures

 

The trusts Audit Committee must pre-approve all audit and non-audit services provided by a funds independent registered public accounting firm relating to the operations or financial reporting of the fund. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.


The Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committees consideration of non-audit services by the audit firms that audit the Fidelity funds. The policies and procedures require that any non-audit service provided by a fund audit firm to a Fidelity fund and any non-audit service provided by a fund auditor to a Fund Service Provider that relates directly to the operations and financial reporting of a Fidelity fund (Covered Service) are subject to approval by the Audit Committee before such service is provided.


All Covered Services must be approved in advance of provision of the service either: (i) by formal resolution of the Audit Committee, or (ii) by oral or written approval of the service by the Chair of the Audit Committee (or if the Chair is unavailable, such other member of the Audit Committee as may be designated by the Chair to act in the Chairs absence). The approval contemplated by (ii) above is permitted where the Treasurer determines that action on such an engagement is necessary before the next meeting of the Audit Committee.


Non-audit services provided by a fund audit firm to a Fund Service Provider that do not relate directly to the operations and financial reporting of a Fidelity fund are reported to the Audit Committee periodically.


Non-Audit Services Approved Pursuant to Rule 2-01(c)(7)(i)(C) and (ii) of Regulation S-X (De Minimis Exception)


There were no non-audit services approved or required to be approved by the Audit Committee pursuant to the De Minimis Exception during the Funds(s) last two fiscal years relating to services provided to (i) the Fund(s) or (ii) any Fund Service Provider that relate directly to the operations and financial reporting of the Fund(s).



Item 5.

Audit Committee of Listed Registrants


Not applicable.


Item 6.  

Investments


(a)

Not applicable.


(b)

Not applicable.


Item 7.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies


Not applicable.


Item 8.

Portfolio Managers of Closed-End Management Investment Companies


Not applicable.


Item 9.  

Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers


Not applicable.


Item 10.

Submission of Matters to a Vote of Security Holders


There were no material changes to the procedures by which shareholders may recommend nominees to the trusts Board of Trustees.


Item 11.

Controls and Procedures


(a)(i)  The President and Treasurer and the Chief Financial Officer have concluded that the trusts disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.


(a)(ii)  There was no change in the trusts internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the trusts internal control over financial reporting.


Item 12.

Disclosure of Securities Lending Activities for Closed-End Management

Investment Companies


Not applicable.


Item 13.

Exhibits


(a)

(1)

Code of Ethics pursuant to Item 2 of Form N-CSR is filed and attached hereto as EX-99.CODE ETH.

(a)

(2)

Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

(a)

(3)

Not applicable.

(b)


Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT.




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Fidelity Central Investment Portfolios LLC



By:

/s/Stacie M. Smith


Stacie M. Smith


President and Treasurer



Date:

August 19, 2022


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



By:

/s/Stacie M. Smith


Stacie M. Smith


President and Treasurer



Date:

August 19, 2022



By:

/s/John J. Burke III


John J. Burke III


Chief Financial Officer



Date:

August 19, 2022